Synthesis, Thermodynamic Behavior, and Enzymatic Properties of Oligonucleotides Containing Nucleoside Analogs. by Cameron, Melissa Anne
Louisiana State University
LSU Digital Commons
LSU Historical Dissertations and Theses Graduate School
1999
Synthesis, Thermodynamic Behavior, and
Enzymatic Properties of Oligonucleotides
Containing Nucleoside Analogs.
Melissa Anne Cameron
Louisiana State University and Agricultural & Mechanical College
Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_disstheses
This Dissertation is brought to you for free and open access by the Graduate School at LSU Digital Commons. It has been accepted for inclusion in
LSU Historical Dissertations and Theses by an authorized administrator of LSU Digital Commons. For more information, please contact
gradetd@lsu.edu.
Recommended Citation
Cameron, Melissa Anne, "Synthesis, Thermodynamic Behavior, and Enzymatic Properties of Oligonucleotides Containing Nucleoside
Analogs." (1999). LSU Historical Dissertations and Theses. 6913.
https://digitalcommons.lsu.edu/gradschool_disstheses/6913
INFORMATION TO USERS
This manuscript has been reproduced from the microfilm master. UMI 
films the text directly from the original or copy submitted. Thus, some 
thesis and dissertation copies are in typewriter fiice, while others may be 
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Abstract
The focus of this research is on base modified nucleosides. By generating these 
nucleosides we hope to find information about the role of “base-stacking” in the 
stability of the DNA duplex and generate nucleoside analogues that could be used as 
conversion agents or in ambiguous positions in probes and primers. The target 
nucleosides included one C-nucleoside 5-(2'-deoxy-p-D-ribofuranosyl)-2- 
hydroxypyrimidine and four 4-substituted pyrazole nucleosides; l-(2'-deoxy-P-D- 
ribofiiranosyl)-4-iodopyrazole, l-(2’-deoxy-P-D-ribofiiranosyl)-4-, l-(2'-deoxy-P-D- 
ribofinanosyl)-4-propynylpyrazole, and l-(2'-deoxy-P-D-ribofuranosyl)-4-(2- 
thiazolyl)pyrazole.
The C-nucleoside was of interest because of its potential anti-viral and anti­
cancer activity and its potential to fimction as a “convertide”. There are several 
potential routes for the synthesis of C-nucleosides. The two routes we attempted were 
based on a palladiimi catalyzed Heck type coupling and a Grignard reaction. Neither 
route was successful. The palladium coupling was hindered mostly by the poorly 
defined reaction conditions and the complex mix of product produced. It was initially 
hampered by the difiBculty in obtaining the requisite glycals for the reaction. This 
problem; however, was addressed by generating protected glycals by the treatment of 
appropriately protected thymidines with hexamethyldisilazane. The Grignard coupling 
route produced mostly addition of the base to the toluoyl protecting group. In addition 
both methods may have been hindered by acid lability of the base.
XV
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The pyrazole nucleosides were easily synthesized by addition of the sodium salt 
of the base to a p-toluoyl protected 1-chlororibose. The pyrazole nucleosides were then 
converted to the phosphoramidites and incorporated into oligonucleotides using 
standard solid phase coupling conditions. Once incorporated into oligonucleotides the 
relative stabilities of the nucleosides were measured by thermodynamic melting.
Overall the thiazolylpyrazole nucleoside was the most stable and the iodopyrazole was 
the least stable. The propynylpyrazole and the nhropyrazole were similar. All four 
nucleosides showed a preference for the purines and were lease stable versus dC. The 
nucleosides were also found to function in PCR reactions. The initial preference for the 
natural nucleoside incorporated versus each modified nucleoside was a dC; however, 
this is most likely a result of impure starting materials.
XVI
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Chapter 1 
Introduction
The existence of DNA (deoxyribose nucleic acids) was first discovered in 1868 
by Friedrich Miescher^ Wio isolated phosphorus containing compounds which he called 
'nuclein' from pus in discarded surgical bandages. It was not until the nineteen fifties, 
however, that the primary structure of the nucleotides was established through work
done by Todd and coworkers^ and Cohn and cowodcers.  ̂Then, following the woric of
several of their contemporaries,^^ Watson and Crick^O proposed the double helix 
secondary structure made of specifically hydrogen bonding pairs Since that discovery 
there has been an explosion of research on the molecule that is the genetic blueprint of
all living things.^ ̂
1.1 Statement of Proposal
The focus of this research is on base modified nucleosides. By generating these 
nucleosides we hope to find information about the role of base stacking in the stability 
of the DNA duplex. In addition the nucleoside analogues could be used as conversion 
agents or in ambiguous positions in probes and primers. Conversion agents refers to the 
use of a nucleoside to change a complementary base from one to another during the 
polymerase chain reaction (PCR). However for this to be accomplished the bases must 
function in PCR. Therefore several nucleosides were designed and tested for stability in 
a duplex by thermal melting and in PCR reactions. The first is 5-(2'-deoxy-P-D- 
ribofuranosyl)-2-hydroxypyrimidine (Figure 1.1, A). The nucleoside was designed to












Figure 1.1 Target nucleosides
function as a conversion agent by “reading” an “A or G” and “writing” an “A”. This is 
accomplished by making use of the tautomerization of the nucleoside which changes its 
pairing selectivity for the natural nucleosides. In addition this nucleoside is a C- 
nucleoside which is of interest in its own right because of the potential for anti-viral and 
anti-cancer properties. The other nucleosides are designed to illuminate the differences 
that charge distribution, polarizability, and size of the heteroaromatic ring have on base 
stacking in the double helix. These nucleosides are non-hydrogen bonding 4-substitued 
pyrazoles, l-(2'-deoxy-P-D-ribofuranosyl)-4-iodopyrazole (Figure 1.1, B),
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
l-(2’-deoxy-P-D-ribofuranosyl)-4-nitropyrazoIe (Figure 1.1, C), l-(2'-deoxy-P-D- 
ribofiiranosyl)-4-propynylpyrazole (Figure 1.1, D), and l-(2'-deoxy-P-D-ribofiiranosyl)- 
4-(2-thiazolyl)pyrazole (Figure 1.1, E).12 
1 Jt Primaiy Structure of DNA
DNA is composed of strands of purine (A,G) and pyrimidine (T,C) bases 
connected by sugar-phosphate backbones. There are four common, naturally occurring 
bases in DNA, adenine and guanine (the purines) and thymidine and cytosine (the 
pyrimidines). When these are attached to the sugar portion (2-deoxyribose in the D- 
furanose form) they are called nucleosides (Figure 1.2). The nucleosides are connected 
to one another by a phosphodiester linkage of the 3'-hydroxyl of one nucleoside to the 










Figure 1,2 Structure of the natural nucleosides
HO
Adenosine (A)
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nucleic acid. One end of the chain bears a 5' phosphate group whereas the other end 




Figure 13 Structure of an oligonucleotide (S'-TCGA-3')
13 Secondary Structure of DNA
Two of the single strands of DNA described above are hydrogen bound together 
through their bases. They are in an antiparallel right handed helix that has the same axis 
for both polynucleotide chains. The hydrogen bonding occurs almost exclusively as 
adenine(A) pairing to thymidine (T) and cytidine (C) pairing to guanine (G)(Figure 1.4). 
This is the Watson-Crick arrangement It is therefore obvious that the sequence of one 
strand dictates the sequence of its complement. The bases of each strand are stacked on 
top of each other making the duplex resemble a ladder. Even indien bases lack a pairing
partner the bases still stack in the h e l ix .




Figure 1.4 Watson-Crick hydrogen bonding of nucleosides
The stability of the duplex is derived from three sources in-plane (hydrogen 
bonding), out-of-plane (base stacking) and the interaction of hydrophobic bases with 
water. The hydrogen bonding is rather self-evident The base stacking occurs because 
the purines and pyrimidines are attracted to each other. At a spacing of 0.36 nm for two 
parallel rings you have optimum interaction of the clouds of tc electron clouds that lie on 
either side of the rings. Oligonucleotides are composed of a hydrophilic sugar 
phosphate backbone which is able to hydrogen bond well with the water and 
hydrophobic bases which do not. Therefore the bases tend to aggregate in the center 
surrounded by the backbone.
1.4 Synthesis of Modified Nucleosides
The original chemical synthesis of nucleosides was to prove their structures. It was 
found that it was more economical to produce the nucleosides by degradation of nucleic 
acids rather than by total synthesis even with advances in stereospecifrc synthesis. 
Chemical synthesis however is often the route of choice for the production of modified 
nucleosides vdiich are useful as metabolism inhibitors, as well as anti-cancer and anti­
viral drugs.
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There have been a number of modified nucleosides and oligonucleotides 
prepared for a variety of reasons. They have been prepared to study the interactions of 
base pairs in double helices, for anti-viral or anti-cancer properties, and to study protein- 
DNA interaction to name a few uses. Every section of the nucleotide has been the 
subject of modification. Examples include the sugar portion being changed to be 
acyclicl^>15 (Figure 1.5, path A) the interaucleotide linkage being changed to 
phosphorthioates ̂  ̂  (Figure 1.5, path B) and phosphordithioates^ ̂  (Figure 1.5, path C)
or the phosphorus being completely replaced!^ (Figure 1.5, path D) and there have been 
numerous modifications to the bases. The base portion of the nucleotides have been
changed to everything fix>m an abasic site or a simple phenyl rmg,^^’̂ ® to slight
modifications of natural bases such as 7 - d e a z a - 2 ’ d e o x y a d e n o s i n e 2 1 » 2 2  jq completely
original multiring systems such as the anthracenyl deoxyguanosine phosphoramidite.^^ 
There have been literally hundreds of base modified nucleosides prepared and reviews
that include discussions of them are extensive and p l e n t i f u l . 2 4 - 2 7
1.4.1 Non-Hydrogen Bonding Nucleoside Analogues
The first appearance of non-hydrogen bonding base modified nucleosides was with 
abasic s i t e s  (Figure 1 . 6 , 1 )  or a phenyl g r o u p ^ O  (Figure 1 . 6 , 2 ) .  Neither of these 
were very stable but the abasic site was more stable than the phenyl. One of the first 
non-hydrogen bonding analogs that possessed some degree of stability (based on Tm)
was 3-nitropyrrole (Figure 1.6,3) synthesized by Bergstrom et This molecule
was designed to be small enough to be incorporated versus purines without disrupting 
H-bonding and to mimic the electronic configuration ofp-nitroaniline, a known DNA














Figure Modifications to oligonucleotides
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intercolator. 3-Nitropyrrole is a relatively universal nucleoside, having a range
of only 3*’C for pairing versus the four natural nucleosides, however, it does show a 
preference for the purines, A in particular. Interestingly, even without any hydrogen 
bonding c^)abilities it was shown to be a fairly stable modified nucleoside more so even 
than deoxyinosine^ 1 although it did have a general destabilizing (lower Tm) effect over 
the fully complementary DNA duplexes. The idea of non-hydrogen nucleosides was 
followed in the same vein by Brown and Loakes with 4-, 5- and 6-nitroindole^^ (Figure 
1.6,4). 5-Nitroindole was found to be the least destabilizing (about 5®C), better even 
then 3-nitropyrrole and it also showed a ATm of 3°C when it was paired with each of the 
natural nucleosides. With all of the nitroindoles, the preference was for pairing with dC.
Kool and co-workers approached the problem from a different angle, instead of 
incorporating heterocycles that mimicked intercolators they synthesized non-hydrogen 
bonding bases that were isosteric and isoelectronic with the natural purines and 
p y r im id i n e s .3 3  Two of the compounds were mimics of dT, diflourotoluene (Figure 1.6, 
5) and trimethylbenzene (Figure 1.6,6), the third was a mimic of dA, dimethylindole 
(Figure 1.6, 7). They found a single incorporation across 6om a natural nucleoside 
lowered the Tm of the duplex ~ 20®C but incorporation of pairs of non-hydrogen 
bonding nucleosides was less destabilizing. For example the Tm of the control 
dodecamer with a T-A pair in the position of interest was 39.4 ®C. When the thymidine 
was changed to diflourotoluene the Tm dropped to 21.4 °C. However when both the 
thymidine and adenine were replaced by diflourotoluene the Tm dropped only to
28.6 ®C. Following the work of Turner and c o w o r k e r s , 3 4  they placed a series of























Figure 1.6 Structures of modified nucleosides
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modified nucleosides in a dangling position of a duplex to determine the effect on 
stability. The series o f nucleosides ranged in size and polarity and were put on the end 
of a DNA duplex in a position that had no pair. They found that the nucleoside analogs 
that were larger and less polar increased the Tm the most.
Bergstrom et investigated the stability of non-hydrogen bases by
incorporating a series of nitro substituted azoles as well as some non-nitro containing 
controls into an olignucleotide. Thty discovered that the role of the nitro group was 
extremely important in stabilization. They also discovered that a ring nitrogen capable 
of hydrogen bonding decreased the “universality” of the nucleoside.
Froehler et found that substituting a propyne substituent onto the C-5
position of cytidine (Figure 1.6,8) and uridine increased the stability because of 
entropie factors caused by the hydrophobic chain displacing water. In addition the 
propynyl unit probably allows increased stacking. Froehler et al.^^ also found that a 
thiazole substituent on the C-5 position increased the stability of a dC (Figure 1.6, 9) or 
a dG. The thiazoyl substituent was postulated to be planar with the heterocycle which 
allows a larger area o f delocalized n electrons which would aid in base stacking.
The design o f the 4-substituted pyrazole nucleosides (Figure 1.1, B-E) was 
chosen because utilizing a small ring size would decrease the likelihood of steric
hindrance when placed versus one of the p u r i n e s . 2 9  The use of nitro, propyne and 
thiazole substituents was chosen to lend added stability as well as allow a progression of 
substituents that varies the electronic charge distribution profiles to determine their 
effect on stability.
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1.4^ C-Nncleoside Analogues
The synthesis of C-nucieosides has been more limited because of the increased 
difficulty of creating the C-C bond over the C-N bond. However, several approaches 
have been developed for the preparation of C-nucleosides.^^’̂ ^’̂ ^"^  This has allowed 
the production of a wide range of C-nucleosides including natural nucleoside mimics 
such as pseudouridine.^5"^^ An extensive review of C-nucleosides was prepared by
Watanabe.24
Daves et have developed a method for the production of C-nucleosides
which utilizes a Pd-catalyzed Heck-type coupling o f aryl-halides to cyclic enol ethers.
This method which is an extension of work performed by Ireland et was the 
method chosen for the synthesis of 5-(2'-deoxy-P-D-ribofiiranosyl)-2-hydroxypyrimidine 
(Figure 1.1, A)
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Chapter 2
Facile Preparatfon of Protected Paranoid Glycals from Thymidine*
2.1 Introduction
The preparation of aryl C-glycosides and C-nucleosides is of intense interest 
because of their potential anti-viral and anti-tumor activity^ ̂  and their use as novel 
base pairing moieties in oligonucleotides.^'^ Several approaches have been developed 
for the preparation of C-glycosides and C-nucleosides including multi-step assembly of 








Scheme 2.1 Strategies for the synthesis of C-nncleosides
of the sugar de novo on the aromatic aglycon (Scheme 2.1, path B),^ electrophilic 
aromatic substitution with a glycosyl cation (Scheme 2.1, path C),^0 and nucleophilic
*Reproduced with permission ftom J. Org. Chem. 1997,62, 9065-9069.
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attack of aiyl organometallics directly onto lactones (Scheme 2.1, path  ̂or 
glycosyl halides (Scheme 2.1, path E).3-6 An alternative strategy for preparation of 
C-nucleosides has been developed by Daves et a i 12-18 which utilizes a Pd-catalyzed 
Heck-type coupling of aryl-halides to cyclic enol ethers, either pyranoid or furanoid 
glycals (Scheme 2.1, path F).
A limitation of this latter approach has been poor accessibility of the furanoid 
glycals, which in contrast to pyranose glycals are highly acid labile. For example, 
reduction of pyranosyl halides by elemental zinc in acetic acid produces good yields of 
pyranose glycals; this method fails for furanosyl g l y c a l s . 2 0  Ireland et al. 2 1  
demonstrated a synthesis of 5-O-protected glycals in four steps from 2,3-isopropylidine 
protected ribonolactone. The overall yield was 60%, but the 5-O-protection possibilities 
were limited and scale up was difScult because of the aluminum hydride reduction, 
chlorination, and dissolving metal reduction required in this route. A modified 
approach was developed by Daves et al. ^2 to allow for differential protection of the 3- 
and 5-hydroxyl groups. The method required six steps with an overall yield of 25%.
The protecting group choices were increased to include silyl protecting groups, but the 
chemistry was still limited because of the need for DEBAl-H reduction, chlorination, and 
Na/NH] reduction. More recently, two groups have developed methods to prepare
glycals firom 2-deoxyribose. Kassou and Castill6n23 have used a selenoxide 
elimination approach to access glycals (3-5 steps, 40-65% yield) that is compatible with 
3- and 5-acyl protection. Townsend and coworicers24 utilized the elimination of a 1-0- 
mesylate on a protected 2-deo3tyribose to prepare mono- or bis-silyl-protected glycals 
(4-5 steps, 20-82% yields).
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Pedersen et al. 25 reported that fiiranose erythro-^ycAs can be produced easily 
from free thymidine or 5'-0-(/err-butyldiphenylsilyI)thymidine (Ic) by using typical 
base silylation conditions; refluxing 1,1,1 ̂ ^,3-hexamethyldisilazane (HMDS), and 
(NH4)2S04 (Eq. 3.1). This approach has the advantage of readily available starting
RO-1 _  N '^ O  HMDS, (NH,kSO« R 0 - ]  n
w  — — — ► <’)
OR' OR'
la-o 2a-o
Eqaation 2.1 Conversion of protected thymidines to glycals
materials, potential compatibility with a wide range of protecting groups, and very 
straightforward experimental procedures. Thus, we envisioned this as an ideal method 
for making up to gram amounts of glycals rapidly and efficiently, as it avoids the 
experimental difrculties of previous glycal preparations (e.g., large scale dissolving 
metal reductions,2i,22 large scale aluminum hydride reductions^i-23) Herein we 
show that this method works very well for preparation of fiiranose glycals with a wide 
range of O-silyl protection. Additionally, 5-O-acyl protected glycals, previously only
accessible by a selenoxide elimination m e t h o d , 2 3  can also be prepared in good to 
excellent yields with this straightforward chemistry.
2.2 Synthesis of Protected Thymidines
Protected thymidines la-o were prepared according to known procedures in one 
(Ib -^ , two (Ih-m) or at most three (In-o) steps (Scheme 2.2 and Experimental). The
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protection groups on the thymidines were introduced by silylation with either /err- 
butyldimethylsilylchloride (TBDMSCi) or /err-butyldiphenylsilylchloride (TBDPSCl) 
and imidazole in DMF or by toluoylation with p-toluoylchloride in pyridine. Where
TBOMS-CI






1b I^TBOMS, R*«H 
1c R-TBDPS, R>H 
1e R>TBOMS, IT-TBDMS 









1h R>TBDMS. R"=TBDPS 












In  RVTBDUS 
1oR>TBOPS
Scheme 2J2 Synthesis of variously protected thymidines
5'-toIuoyl groups were used as temporary protection, they were removed by treatment 
with ammonia in methanol.
23  Conversion to Glycals
On -0.2-3 mmol scales, the thymidines were treated under Pedersen's conditions 
(Equation 2.1) and all, except for the 3'-0-toluoyl protected thymidines (lg,li,lk), 
were converted to the corresponding protected glycals (Table 2.1). In the cases where a 
free hydroxyl group was present (2b-2d, 2n, 2o), the initial product formed (according 
to NMR) was the O-trimethylsilyl (TMS) derivative. Using standard work-up 
conditions, the TMS group was cleaved and the free hydroxyl compound was isolated. 
For optimal glycal yields, heating should be discontinued as soon as all the nucleoside is
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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Table 2.1 Product yields for glycals
thymidine glycal R R’ Yield (%)6.c Yield (%) 
from la^
la 2a« H H 80 80(1)
lb 2be TBDMS H 74 53(2)
Ic 2c« TBDPS H 91 70(2)
Id 2d Toi H 52 38(2)
le 2e« TBDMS TBDMS 69 47(2)
If 2fe TBDPS TBDPS 80 76(2)
Ig 2g Toi Toi a a
Ih 2h TBDMS TBDPS 79 55(3)
li 2i TBDMS Toi a a
Ij 2j TBDPS TBDMS 59 40(3)
Ik 2k TBDPS Toi a a
11 21 Toi TBDMS 74 39(3)
Im 2m Toi TBDPS 94 64(3)
In 2n H TBDMS 36 18(4)
lo 2o H TBDPS 79 53(4)
glycal product obtained.  ̂Isolated yield after chromatography. ^ Purified silyl-
protected glycals decompose readily at room temperature, though they may be stored in 
the freezer up to several weeks. In contrast, the 5-O-toluoyl glycals (2d, 21,2m) are 
stable at room temperature for several days and appear to be indefinetely stable in the 
fieezer. ^ The number in parentheses indicates the number of steps required to prepare 
the glycal 6 om commercially available free thymidine la .  ̂A separate time course 
experiment was run to determine the rate of glycal formation for several o f the protected 
thymidines: Thymidine (la-lc, le. If; 0.1 mmol), (NH4)2S04 (0.5 g, 3.8 mmol) in 
HMDS (5 mL). Reaction mixtures were lowered simultaneously into preheated oil 
baths and all started refluxing within 30 s. Disappearance of starting material (TLC, 
GC) was considered as the end of the reaction. Reaction times: 2a, 170 min.; 2b, 125 
min.; 2c, 145 min.; 2e, 180 min.; 2f, 180 min.
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consumed (TLC). In general, the crude products 6 om extraction are pure enough for 
further reactions, though we report here yields after flash chromatographic purification 
(Table 2.1).
23.1 Discussion
Yields of glycal products with O-TBDMS protection were always lower than 
analogous TBDPS derivatives [e.g., 2b (74%) vs. 2c (91%); 2e (69%), 2j (59%) vs. 2f 
(80%); 21 (74%) vs. 2m (94%); 2n (36%) vs. 2o (79%)]. This suggests some cleavage 
of TBDMS ethers under the slightly acidic conditions of the reaction or overall lower
stability of the TBDMS glycals. As previously noted by P e d e r s e n ,2 5  thymidines in 
which a 3'-ester group was included (Ig, li, Ik) produced no isolable glycal products 
though starting material was consumed slowly^^ to form furfuryl alcohol d e r i v a t i v e s . ^ ^  
The 5 -0-toluoyl-thymidines (Id, II, Im) were successfully converted to the 
corresponding glycals and were found to be much more stable to storage than those with 
only silyl protection (Table 2.1, foomote c).
2 3 3  Proposed Mechanism
The mechanism proposed by Pedersen et al. is consistent with these results. The 
base is first silylated to give 3 (Scheme 2.3) which imdergoes an elimination to give 
the intermediate oxonium ion 4 and then the glycal 1. The thymidines with toluoyl 
groups on the 3 -0  yield no glycals because the ester acts as a leaving group that could 
allow for the formation o f fiirfuryl alcohol (Scheme 2.3).
2.4 Conclusions
Using Pedersen's method, we have prepared furanoid glycals having both O-silyl 
and, for the first time, 5-O-acyl protection. The advantages of this method are the




—  „ w > .
R'O ^
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Scheme 23  Proposed mechanism of glycal and fiirfuryl alcohol formation
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greater generality of protecting groups that can be used and the speed and experimental 
ease with which glycals can be made. Previous methods for preparing fiiranose glycals 
starting from ribonolactone require at least six steps and are difGcult to scale up because 
of the required sequential DIBAl-H reduction, low temperature chlorination, and 
Na/NH] reduction. The more recent approaches to glycals from 2 - d e o x y r i b o s e ^ 3 , 2 4  are 
much improved, but still have some disadvantages relative to the Pedersen route from 
thymidine. The Castillon method requires use of the toxic, pungent, and expensive 
reagent benzeneselenol. Townsend's approach requires a low-temperature reduction 
step that is incompatible with 5-O-ester protection (e.g., 2d, 2j, 21,2m). Yields of 
glycals made herein under Pedersen conditions, including the four previously unknown 
glycals 2d, 2j, 21,2m, are comparable to those acheived by Townsend, and the Pedersen 
method is always one less step from commercially available material: bis-O-TBDMS 
glycal 2e, 2 steps from thymidine (la), 47% yield, or 3 steps from 2-deoxyribose, 63% 
yield; bis-OTBDPS glycal 2f, 2-steps from la, 76% yield, or 3 steps from 2- 
deoxyribose, 80% yield; 3-O-TBDPS glycal 2o, 4-steps from la , 53% yield, or 5 steps 
from 2-deoxyribose, 20% yield. Gram quantities of furanoid glycals can now be 
prepared in a few days using standard nucleoside protection chemistry and typical 
HMDS silylation conditions. Improved access to differentially protected 5-member 
glycals should greatly increase their potential as intermediates in organic synthesis, 
especially for preparation of aryl- and heteroaryl-2-deoxy-C-furanosides. 17,18
2,5 Experimental
NMR spectra were collected on Broker AC-200, AC-250 or ARX-300 FT NMR 
spectrometers. NMR data are listed in ppm (5) using TMS as an internal reference.
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NMR data are listed in 5 ppm using solvent peaks and TMS as references. The 
peaks were assigned with the aid of COSY, DEPT and HETCOR. Melting points were 
performed on a Fisher-Johns hot plate apparatus. FABMS was performed on a Finnigan 
MAT-900 double sector mass spectrometer equipped with a PATRIC detector or a VG 
7070E-HF using m-nitroben^l alcohol (NBA) or glycerol as the matrix. CIMS was 
performed on a Finnigan MAT-95 double sector mass spectrometer using NH3 or 
isobutane as the carrier gas. Microanalyses were performed by M-H-W Laboratories 
(Tucson, Arizona). Colunm chromatogr^hy procedures utilized silica gel (Merck, 230- 
400 mesh) or alum ina (Aldrich, Basic, Brockman 1 ,150 mesh). Thin layer 
chromatography (TLC) was carried out using Merck plates coated with Silica Gel 60 
F254 (0.25 mm thickness). Anhydrous DMF was from Aldrich (Sure-Seal bottle), and 
pyridine was distilled from CaH;.
2.5.1 Method A. General Conditions for Silylation: Synthesis of S'-0-{tert- 
Butyldimethyl)-3-€)-(tlerr-bu^ldiphenylsi]^l)thymidine (1 h).̂ ^
5'-0-(/err-Butyldimethylsilyl)thymidine (lb ) (3 J7  g, 9.46 mmol) was 
introduced to a dried flask under Ar. DMF (40 mL) was added, and the solution was 
stirred until lb  dissolved. Imidazole (2.07 g, 30.40 mmol) was added followed by 
TBDPSCl (3.17 g, 11.54 mmol). The solution was stirred for 24 hours. It was poured 
into water (500 mL) and extracted with ether (3 x 250 mL). The ether layer was then 
washed with aqueous NaHCOs (200 mL) followed by distilled water (200 mL). It was 
dried with Na2S04 and ev^x>rated under reduced pressure to give a clear oil. This was 
purified by flash chromatogr^hy (hexanes then ether) to yield a white solid (5.5 g,
98%). TLC: ^0 .9 1  (9:1 CHCI3-CH3OH); m.p. 56 °C; FABMS (NBA) 596.5 (M +
H)+; IH NMR (250 MHz, CDCI3) 5 9.62 (s, IH, H3), 7.67-7.63 (m, 4H, Ar cmdH6),
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7.47-7.37 (m, 7H, Ar), 6.53 (dd, Jm' = 5.5, Jm- = 8 9 Hz, IH, ff/%  4.34 (d, J =  5.2 Hz, 
IH, 4.00 (s, IH, 3.63 (dd, Jh4> = 1-3, V^ = 11.0Hz,lH, ffS% 3.14 (dd, Jh4’ =
1.8, Jh5- =  10.9 Hz, IH, 2.34 (dd, J =  5.3,13.0 Hz, IH, H2% 1.87 (s, 3H, C S-C H i) 
1.85-1.82 (m, IH, H2 '), 1.09 (s, 9H, C (C H 3 )3 l  0.78 (s, 9H, C (C H 3 )3 \  -0 07 (s, 3H, S i- 
CHs), -0.11 (s, 3H, Si-CHs). NMR (62.9 MHz, CDCI3) S 164.04 (C4), 150.45 
(C2), 135.61 (C6), 135.38,133.25,133.03, 129.89,127.77 (Ar), 110.71 (C5), 87.97 
(C4% 84.97 (CIO, 74.15 (C30,63.14 (C50,4125 (C20,26.80 ( € ( ^ 3)3), 25.71 
(C(CH3)3>, 18.94 (C(CH3)3), 18.11 (C(CH3)3), 12.32 (CH3), -5.60 (Si-CH3), -5.78 (Si- 
CH3).
2,52 Method B. General Conditions for Toinoyiation: Synthesis of 5'-0-{tert- 
Bntyldimethylsityl)-3'-t^^toIuoyI)thyniidine (li).
5'-0(rer/-ButyldimethyisiIyl)thyinidine (Ib) (0.207 g, 0.58 mmol) was 
introduced to a dried flask under Ar. Pyridine (5 mL) was added and the solution was 
cooled to 0 ®C. The /7-toluoyl chloride (0.15 mL, 1.13 mmol) was added slowly over 15 
minutes. The solution was allowed to warm to room temperature followed by heating to 
50-55 °C for 4 hs. Then, it was cooled to room temperature and poured onto ice 
followed by an extraction with CH2CI2. The organic layer was washed with aqueous 
NaHCOg and then distilled water. The washed layer was dried with Na2S04 and 
concentrated under reduced pressure. It was reciystallized from CH2CI2 to yield a white 
soUd (0.219 g, 80%). TLC: R/0.84 (1:2 CH2Cl2-EtOAc); m.p. 173 °C; FABMS (NBA)
475.2 (M + H)+; IH NMR (300 MHz, CDCI3) S 8.84 (s, IH, H3), 7.95-7.92 (m, 2H,
Ar), 7.61 (app d, /mc = 1.2 Hz, IH, ffâ), 7.28-7.25 (m, 2H, Ar), 6.48 (dd, Jic  = 5.3, Jia- 
= 9.3 Hz, IH, fflO, 5.49 (d, /=  6.1 Hz, IH, H3% 4.25 (s, IH, 4.04 (dd, = 2.0,
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JHy=ll-3Hz, lH,Æ?'),3.97(dd,yH4 = 1.9,yH5’= n .3 H z , \H,H5% 2.5% idd,Jw  =
5.3, JHZ' = 13.8 Hz, IH, H2% 2.42 (s, 3H, CS-CHj), 2.27-2.19 (m, IH, H2'), 1.95 (c^^hô 
= 1.0 Hz, 3H, Ar-CHj), 0.96 (s, 9H, CrCBj^s), 0.17 (s, 6H, S 1-CH3). l^C NMR (75 
MHz,CDCl3) 6 166.28 (C(O)-Ar), 163.64 (C4), 150.40 (C2), 144.38 (C(O)-Ar), 135.12 
(C6), 129.77,129.26 (Ar), 126.57 (Ar-CHj), 11127 (C5), 85.66 (C4'), 84.86 (Cl"),
75.84 (C3"), 63.74 (C5’>, 38.21 (C2’), 25.91 (€ (€ « 3)3), 21.72 (Ar-CHj), 18.37 
(C(CH3>3), 12.52 (C5-CH3), -5.34, -5.43 (Si-CHj). Calcd for C24H34N206Si*H20: C 
58.51, H 7.37, N 5.69. Found: C 58.38, H 6.72, N 5.78.
2JS3 Method C. General Conditioiis for Detoluoylation: Synthesis of 3'-0-(/er/- 
Butyldhnethyb%l)thymidine (ln).29
3'-0-(/e/t-Butyldimethylsilyl)-5-0-(p-toluoyl)thymidine (II) (0.062 g, 0.13 
mmol) was introduced into a dried flask under N2. NH3-saturated CH3OH (10 mL) was 
added. Additional NH3(g) was bubbled through the solution for 5 min, and the reaction 
was left to stir for 24 hs. It was evaporated under reduced pressure to an oil that was 
purified by flash chromatography (EtOAc) to yield a Wiite solid (0.044 g, 95%). TLC:
Rf 0.12 (EtOAc); m.p. 90 ®C (lit 83-84 °C); FABMS (glycerol) 357.2 (M + K f ; iH 
NMR (200 MHz, CDCI3) S 8.88 (hr, IH, MS'), 7.37 (app d, 2mc =11 Hz, IH, H6 % 6.14 
iUJ= 6.7, IH, Hl%  4.49 (m, IH, //i%  3.96-3.89 (m, 2H, H 4’and MS'), 3.76 (m, IH, 
H5X 2.72 (br, OH), 2.43-2.15 (m, 2H, H2% 1.91 (d, Jke = 0.9 Hz, 3H, CS-CHj), 0.89 
(s, 9H, C(CH3)3), 0.09 (s, 6H, &-C%). 13C NMR (62.9 MHz, CDCI3) 8 163.67 (C4), 
150.30 (C2), 136.98 (C6), 110.99 (C5), 87.58 (C4*), 86.94 (C l'), 71.60 (03*), 62.02 
(C5'), 40.48 (C2") 25.69 ( € ( ^ 3)3), 17.93 (C(CH3)3), 12.47 (C5-CH3), -4.72, -4.87 (81- 
CH3).
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2.5.4 Method D. General Conditions for Gfycal Formation: Synthesis of 1,4- 
Anhydro-3,5-bis-O-(/eft-bntyldiphenyisilyi)-2-deo^-D-eiylftr0-pent-l-enitol(2f).2^
3', 5'-Bis-0-(rerf-butyldiphenylsilyl)thymidine (If) (0.99 g, 1.38 mmol) was
introduced to a dried flask under Ar. HMDS (10.0 mL, 47.3 mmol) was added and the
solution was stirred until dissolved. After the addition of the (NH^^gSO  ̂(0.29 g, 2.19
mmol), the solution was refluxed for 4 hours. The HMDS was evaporated under
reduced pressure and the residue was partitioned between water and cyclohexane. The
organic layer was washed with aqueous NaHCOs and then distilled water. It was dried
with Na2S04 and evaporated under reduced pressure to give a yellow oil that was
purified by alumina flash chromatography (1:2 ether-hexanes) (0.648 g, 79%). TLC: Rf
0.65 (1:2 ether-hexanes); FABMS (NBA) 591.3 (M - H) ;̂ ‘H NMR (200 MHz, CDCI3) 
6 7.79-7.62 (m, 9H, Ar), 7.48-7.36 (m, IIH , Ar), 6.51 (d, Jh2 = 2.3 Hz, IH, HI), 4.99 (t, 
y=  2.0 Hz, IH, H2), 4.92 (m, IH, H3), 4.59-4.53 (m, IH, H4), 3.49-3.45 (m, 2H, HS), 
1.12,1.03 (2s, 18H, C(CHs)3). NMR(50 MHz, CDCI3) S 149.28 (Cl), 135.80, 
135.61,134.96, 134.86, 134.15, 134.01, 129.66, 129.34,127.68, 127.51 (Ar), 103.43 
(C2), 89.17 (C3), 76.99 (C4), 63.80 (C5), 26.93,26.77 (C(CH3)3>, 1922, 19.07 
(C(CH3)3).
2.5.5 Synthesis of 5'-0-(^^'*Butyldimethylsifyl)thymidine (Ib).^^
Prepared according to Method A from la  (0.402 g, 1.66 mmol) and TBDMSCI 
(0.320 g, 2.12 mmol). Product was purified by flash chromatography (EtOAc) to yield a 
white sohd (0.505 g, 71%). TLC: RfO.57 (9:1 CH2CI2-CH3OH); m.p. 200 °C (lit 198- 
199 ®C); FABMS (NBA) 357.3 (M + H)+; *H NMR (300 MHz, CDCI3) Ô 8.56 (br, IH, 
H3), 7.52(appd,JMe= 11 Hz, IH,H 6 ), 6.38 (dd, Jh2 = 8-U^H2- = 5.7Hz, IH,H1%
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4.46 (br, IH, MS'), 4.05 (dd, J =  4.7,2.6 Hz, IH, H4% 3.90 (dd, Jhs- = 11 -3, Jwv = 2.7 
Hz, IH, H5% 3.83 (dd, =11.3, Jwv = 2.6 Hz, IH, MS'), 2.65 (br, IH, OH), 2.38 (ddd, 
Jvx ~ 13.5, J\\\' — 5.7, t/H3' ~ 2.3 Hz, IH, H2% 2.10 (ddd, Jh2' ~ 13.5, ̂ Hr ~ 8.0, J\q< — 5.8 
Hz, IH, H 2 \ 1.92 (d, Jh6=1.0 Hz, 3H, C5-C%), 0.92 (s, 9H, C(CH^i), 0.12,0.11 (2s, 
6H, Si-CHs). 13C NMR (75 MHz, CDCI3) 5 164.0 (C4), 150.6 (C2), 135.7 (C6), 111.1 
(C5), 87.4 (C4'), 85.2 (Cl*), 72.8 (C3*), 63.8 (C5*>, 41.3 (C2*), 26.1 (€ (€ ^ 3)3), 18.6 
(C(CH3>3), 12.7 (C5-CH3), -5 .2, -5.3 (Si-CHj).
2.5.6 Synthesis of 5*-0-(/err-Butyldlphenylsilyi)thyniidlne (lc).2530
Prepared according to Method A from la (0.211 g, 0.87 mmol) and TBDPSCl 
(0.159 g, 0.58 mmol). It was purified by flash chromatography (EtOAc) to yield a white 
soUd (0.322 g, 77%). TLC: R/0.37 (1:2 CHiCli-EtOAc); m.p. 162 °C (lit 163-164 °C); 
FABMS (glycerol) 481.3 (M + H)+; ^H NMR(300 MHz, CDCI3) Ô 8.57 (br, IH, H3\ 
7.67-7.64 (m, 4H, A r\ 7.48-7.37 (m, 7H, H6  andAr), 6.39 (dd, Jm.' = 5.7, Jm' = 8.1 Hz, 
IH, HI'), 4.57 (br, IH, iW*), 4.02-3.95 (m, 2H, H4'andH5'), 3.85 (dd, = 10.8, J ^ '
= 2.1 Hz, IH, H 5 \ 2.40 (ddd, = 13.5, Jh3- = 7.8, /„!• = 2.6 Hz, IH, H2'), 2.25-2.15 
(m, 2H, H2'and OH), 1.64 (s, 3H, CHj), 1.09 (s, 9H, C(CHs)3). * ̂ C NMR (62.9 MHz, 
CDCl3)S 135.7 (Ar), 135.5 (C6), 133.1,132.6,130.4, 130.3, 128.2 (Ar), 111.2 (C5),
87.1 (C4*), 84.7 (Cl*), 72.2 (C3*) 64.1 (C5*), 41.0 (C2*) 27.0 (C(CH3)3), 19.4 ( € ( ^ 3)3),
12.1 (C5-CH3).
2.5.7 Synthesis of 5’-0-(p-toluoyl)thymidme(ld).31
Prepared according to Method B from la  (1.977 g, 8.16 mmol). The product 
was recrystallized from CH2CI2 to yield a white solid (2.170 g, 74%). TLC: Rf 0.62
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(9:1 CH2CI2-CH3OH); m.p. 198 ®C (lit. 202 ®C); FABMS (glycerol) 361.0 (M + H)+;
NMR (250 MHz, CDCI3) 5 8.22 (br, IH, H 3\ 7.92 (d, Jf^ = 8.0 Hz, 2H, Ar), 7.56 (s, 
IH, 7.28-7.26 (m, 2H, Ar), 6.35 (dd, = 6.9, = 12.9 Hz, IH, 4.61 (d,
Jh4* = 2.9 Hz, 2H, 7̂ 5"), 4.52 (br, IH, i/i*), 4.26 (d, 7 =  2.3 Hz, IH, 2.57-2.52 (m, 
IH, /KO, 2.43 (s, 3H, CHs-Ar), 2.24-2.13 (m, IH, H2% 1.61 (s, 3H, CS-CHj), 1.43 (br, 
O//). NMR (62.9 MHz, CDCI3) Ô 167.2 (C(0)>, 163.1 (C4), 144.6 (Ar-C(O)),
134.9 (C6), 129.62,129.4 (Ar), 129.3 (Ar-CHj), 111.1 (C5), 85.0 (C40,84.6 (Cl*), 71.6 
(C30,63.7 (C50,40.7 (C2'), 21.7 (CHj-Ar), 12.3 (C5-CH3).
2,5.8 Synthesis of 3*,5*-Bis-0-(tleif-batyldimethybifyl)thymidme (le).29
Prepared according to Method A from la  (1.073 g, 4.43 mmol), twice the 
amount of imidazole (0.722 g; 10.60 mmol), and TBDMSCI (1.70 g; 11.28 mmol). It 
was purified by flash chromatography using 6:1 hexanes-ether to yield a white solid 
(1.41 g, 68%). TLC: Rf0.6\ (1:2 CHiCli-EtOAc); m.p. 140 °C (Ut. 144-145 °C); 
FABMS (glycerol) 471.4 (M + H)+; ‘H NMR (300 MHz, CDCI3) 6 9.33 (s, IH, H3),
7.47 (app d, Ace = 1.2 Hz, IH, H6), 6.34 (dd, Ac’ = 7.8, Ac- = 5.8 Hz, IH, Hl% 4.41 (m, 
IH, 70% 3.94 (d, J =  2.4 Hz, IH, H4), 3.89 (dd, Acs- =11.3, Ac4-=2.6 Hz, IH, 70% 3.76 
(dd, Acs' — 11.4, Ac4‘ = 2.5 Hz, IH, 775% 2.26 (ddd, Acr = 5.8, A c = 2.7, A c = 13.1 Hz, 
IH, 772% 2.02 (m, IH, 772% 1.92 (d, Ae = 11 Hz, 3H, C5-C%), 0.93,0.90 (2s, 18H, 
C(CH3)3), 0.12,0.08 (2s, 6H, Si-CHs). NMR (75 MHz, CDCI3) S 164.2 (C4),
150.6 (C2), 135.6 (C6), 111.0 (C5), 88.0 (C4% 85.0 (Cl% 72.4 (C3% 63.1 (C5% 41.6 
(C2% 26.1,25.9 (C(CH3)3), 18.6, 18.2 (C(CH))3), 12.7 (C5-CH3), -4.5, -4.7, -5.2, -5.3 
(SÎ-CH3).
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2.5.9 Synthesis of 3%S-Bis-O^^f^butylphenybilyiythynudine (If).̂ ^
Prepared according to Method A from la (0216 g, 0.90 mmol), twice the 
amount of imidazole (0.333 g; 4.88 mmol), and TBDPSCl (0.317 g; 1.15 mmol). It was 
purified by flash chromatography with 1:2 EtOAc-hexanes to yield a clear oil (0.63 g,
95 %) TLC: R/OM  (1:2 CHzClz-EtOAc); FABMS (NBA) 719.5 (M + H)+; NMR 
(300 MHz, CDCI3) Ô 9.51 (s, IH, H3), 7.65-7.25 (m, 21H, Ar and H6), 6.55 (dd, Jh2’ =
8.8, Jh2' = 5.3 Hz, ih , ///% 4.56 (d, J =  5.1 Hz, IH, H3% 4.01 (s, IH, H4'), 3.76 (d, Jus' 
= 11.5 Hz, IH, H5X 3.32 (d, Jhs- = H-4 Hz, IH, MS'), 2.36 (m, IH, HZ’), 1.97 (m, IH, 
HZ’), 1.52 (s, 3H, C5 -CH3), 1.09,0.94 (2s, 18H, C(C%)j). NMR (62.9 MHz, 
CDCl3)6 164.3 (C4), 150.7 (C2), 135.9, 135.8,135.6, 135.5, 133.4, 133.3,133.1,
132.3, 130.2,130.1,127.9 (Ar), 111.3 (C5), 87.9 (C4"), 84.9 (Cl"), 74.1 (C3"), 64.2 
(C5"), 41.5 {CT), 27.1 (dC H sh). 19.4, 19.2 (C(CH3)3), 12.1 (C5-CH3).
2.5.10 Synthesis of 3\5-Bis-0-(p-toluoyi)thymidine (Ig).^^
Prepared according to Method B from la (2.064 g, 8.52 mmol) and an excess of 
/7-toluoylchloride (5.845 g; 37.81 mmol). It was purified by recrystalization from 
CH2CI2 to yield a white solid (2.87 g, 70%). TLC: RfOA9 (1:2 ether-hexanes); m.p.
167 °C (lit. 143 «C); FABMS (NBA) 479.3 (M + H)+; *H NMR (300 MHz, CDCI3) 5 
7.97-7.90 (m, 4H, Ar), 7.80 (d, J =  8.3 Hz, 2H, Ar), 7.36 (app d, J =  1.2 Hz, IH, H6), 
7.31-7.23 (m, 2H, Ar), 6.45 (dd, Jm' = 5.4, = 8.8 Hz, IH, /// ') , 5.6 (d, J=  6.5 Hz,
IH, HZ’), 4.82 (dd, Jy^ = 2.9, Jhs- = 12.3 Hz, IH, HZ’), 4.67 (dd, J ^ ' = 3.3, Jhs* = 12.3 
Hz, IH, HZ’), 4.53 (dd, 7h5- = 2.9, Jm- = 5.1 Hz, IH, H4’), 2.72 (ddd, Jhv = 5.4, =
1.3, Jyu' = 14.2 Hz, IH, HZ'), 2.44 (s, 3H, Ar-CHj), 2.41 (s, 3H, Ar-CHj), 2.39-2.29 (m.
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IH, H2X 1.66 (d, Jm  = 0.9 Hz, 3H, CS-CHi). NMR (75 MHz, CDCI3) 6 168.4,
166.1 (C(0)-Ar), 162.5 (C4), 149.3 (C2), 146.4, 144.7 (C(O)-Ar), 134.1 (C6), 130.6,
129.9,129.6,129.3, 129.0 (Ar), 126.6,126.2 (Ar-CHj), 111.7 (C5), 85.2 (€4*), 83.0 
(Cl-), 74.9 (C3"), 64.1 (C5’>, 38.1 (C2*), 21.9,21.7 (Ar-CHj), 12.3 (C5-CH3).
2.5.11 Synthesis of 3'-0-(/err-batyidimethylsifyl)-5*-0>(/e/t-batyldiphenylsilyl) 
thymidine (lj).30
Prepared according to Method A from Ic (0.762 g, 1.59 mmol) and TBDMSCI 
(0.60 g, 3.98 mmol). The product was purified by flash chromatography (1:3 ether- 
heanes) to yield a white solid (0.844 g, 89%). TLC: 0.87 (EtOAc); m.p. 69 °C;
FABMS (NBA) 596.0 (M + H)+; ^H NMR (250 MHz, CDCI3) 8 8.05 (s, IH, H 2\ 7.67- 
7.64 (m, 4H, Ar), 7.48-7.31 (m, 7H, Ar cmdH6), 6.36 (dd, Jh2’ ~ 8.0, Jh2’ “ 5.8 Hz, IH, 
H n , 4.50 (d y=  5.8 Hz, IH, MS'), 3.96 (m, 2H, H4’andH5% 3.77 (dd, 7h4- = 3.6, Jhs’ = 
12.5 Hz, IH, H5% 2.28 (ddd, J»r = 10.8, Jw  = 5.7, Jm- = 3.2 Hz, IH, H2% 2.10 (m,
IH, H2'), 1.64 (s, 3H, C5-OT,), 1.09 (s, 9H, C(CH^3\  0.87 (s, 9H, C(CH^i), 0.018 (s, 
3H, Si-CMs), 0.00 (s, 3H, Si-CHs). NMR (50 MHz, CDCI3) 8 163.9 (C4), 150.3 
(C2), 135.0,134.8, 132.3, 131.9, 129.6,127.5 (Arand C6), 110.6 (C5), 87.2 (C4"), 84.2 
(Cl"), 71.7 (C3"), 63.2 (C5"), 41.0 (C2"), 26.5,25.3 (C(CH3)3), 18.8,17.5 (C(CH3)3),
II.7 (C5-CH3), -5.1, -5.4 (Si-CH3).
2.5.12 Synthesis of 5 -0-(tkrt-Bn^ldiphenybilyl)-3-0-(^tolnoyl)thymidine (Ik).
Prepared according to Method B from Ic (1.026 g, 2.19 mmol). The product 
was purified by recrystallization using CH2CI2 to yield a white solid (0.888 g; 69%).
TLC: /Î/0.84 (1:2 CH2CI2 -EtOAc); m.p. 170 ®C; FABMS (NBA) 599.4 (M + H)+; ^H
NMR (250 MHz, CDCI3) 8 9.46 (s, IH, Æ3), 7.96-7.93 (m, 2H, Ar), 7.72-7.67 (m, 4H,
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ArX 7.55 (br, IH, Ar), 7.46-7.37 (m, 6H, Ar and H6), 1728-7.25 (m, 2H, Ar), 6.55 (dd, 
Jm' = 5.2, = 9.2 Hz, IH, H2% 5.71 (d, J=  6.0 Hz, IH, H3% 4.24 (br, IH, H 4 \ 4.08
(br, 2H, US'), 2.63 (dd, Jh2- = 5.4, Jh2- = 13.8 Hz, IH, H2’), 2.45-2.17 (m, 4H, H2’ and 
CHs-Ar), 1.56 (s, 3H, CS-CHj), 1.13 (s, 9H, NMR (62.9 MHz, CDCI3) Ô
166.1 (C(0)-Ar), 163.8 (C4), 150.6 (C2), 144.23 (C(O)-Ar), 135.5, 135.2, 134.9,133.0, 
132.1,130.1,130.0, 129.7, 129.2, 128.1, 128.0 (Ar), 126.6 (Ar-CHj), 111.6 (C5), 85.2 
(C4*), 84.4 (Cl*), 75.2 (C3’), 64.3 (C5’), 38.1 (C2"), 27.0 (C(CH3)3), 21.7 (Ar-CHj), 19.4 
(C(CH3>3), 11.9 (C5-CH3). Anal. Calcd for C34H3gN206Si: C 68.20. H 6.40, N 4.68. 
Found: C 67.96, H 6.17, N 4.64.
2,5.13 Synthesis of 3 -0 -(t^rt^Bn^ldimethylsilyI)-S-<X^toluoyI)-thym:dine (II),
Prepared according to Method B from Id (0.48 g, 1.33 mmol). Purification was 
done by recrystallization fix>m CH2CI2 to yield a white solid (0.4508 g, 71%). TLC: R f 
0.52 (9:1 CHCI3-CH3OH); FABMS (glycerol) 475.1 (M + H)+; ‘H NMR (250 MHz, 
CDCI3) 5 7.90 (d, = 7.8 Hz, 2H, Ar), 7.28-7.25 (m, 3H, Ar and H6), 6.30 (t, J^^. =
6.6 Hz, IH, "), 4.61 (dd, = 3.6, ̂ 5. = 12.5 Hz, IH, MS'), 4.49-4.43 (m, 2H, H3’ 
and MS’), 4.20 (dd, J=  3.6,6.9 Hz, IH, H4'), 2.43 (s, 3H, Ar-CHj), 2.37 (ddd, J ^ . =
2.7, = 6.0, = 13.7 Hz, IH, H2'), 2.16-2.05 (m, IH, H2'), 1.67 (s, 3H, CS-CH j),
0.90 (s, 9H, C(CHs)), 0.10 (s, 6H, Si-C H i).  ‘^C NMR (62.9 MHz, CDCI3) 6 166.2 
(C(0)), 163.4 (C4), 150.0 (C2), 144.4 (Ar-C(O)), 135.0 (C6), 129.5 (Ar), 129.4 (Ar),
126.7 (Ar), 111.1 (C5), 85.5 (C40, 85.1 (Cl*), 72.0 (C3"), 63.6 (C5"), 41.2 {Cl), 25.7 
(C(CH3)3), 21.7 (Ar-CH3), 17.9 (C(CH3)3), 12.2 (C5-CH3), -4.7, -4.8 (Si-CH3). Anal. 
Calcd for C24H34N206S1: C 60.73, H 7.22, N 5.90. Found: C 61.20, H 7.05, N 5.75.
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2^.14 Synthesis of 3*-0-{t<ert‘-Batyidiphenyisifyl)-5'-0-(/^-tolaoyI)thymidme(lm).
Prepared according to Method B from Id (0.600 g, 1.66 mmol). The product 
was purified by recrystallization fix)m CH2CI2 to yield a white solid (0.9211 g, 92%). 
TLC: ^0 .48  (9:1 CHCI3-CH3OH); m.p. 74 °C; FABMS (glycerol) 599.0 (M + H)+;
•H NMR (250 MHz, CDCI3) 5 8.03 (br, H3), 7.74 (d, 2H, A r\ 7.69-7.63 (m,
4H, Ar), 7.45-7.33 (m, 6H, Ar and H6), 7.23 (d, = 7.2,2H, Ar), 6.40 (t,J=  7.2 Hz,
IH, Hl% 4.48-4.44 (m, IH, H3% 4.34 (dd, = 2.9, = 12.6 Hz, IH, H 5 \ 4.22
(dd, J=  2.9,5.9 Hz, IH, H4% 3.86 (dd, = 3.3, = 12.0 Hz, IH, H5% 2.51-2.42
(m, IH, H2'), 2.42 (s, 3H, Ar-CHs), 1.99-1.88 (m, IH, H2% 1.53 (s, 3H, C5-CH3), 1.10 
(s, 9H, C(C%)j). »3c NMR (50 MHz, CDCI3) Ô 165.9 (C(0)), 163.2 (C4), 149.9 (C2),
144.4 (Ar-C(O)), 135.7, 134.8, 132.8,130.3,130.2, 129.5, 129.3, 128.0,127.7 (Ar),
126.6 (Ar-CHs), IH  l (C5), 85.0 (C4% 73.0 (C3’), 63.4 (C5"), 41.0(C2"), 26.9 
(C(CH3)s), 21.7 (Ar-CHj), 19.0 (C(CHs)3), 12.1 (C5-CH3). Anal. Calcd for 
C34H3gN206Si: C 68.20, H 6.40 N, 4.68. Found: C 67.99, H 6.45, N 4.46.
2.5.15 Synthesis of 3*-0-(l!ert-BntyldiphenylsilyI)thymidine (lo).^^
Prepared according to Method C finm Im (0.349 g, 0.58 mmol). The product 
was purified by flash chromatography using 1:2 CH2Cl2-EtOAc to yield a white solid 
(0.279 g, 99%). TLC: R/0.33 (1:2 CH2Cl2-EtOAc); m.p. 89 °C (lit. 77 °C); FABMS 
(glycerol) 481.6 (M + H)+; ‘H NMR (200 MHz, CDCI3) 5 9.29 (br, IH, H3), 7.17-7.62 
(m, 4H, Ar), 7.46-7.32 (m ,7U ,Arand H6), 6.26 (dd, J^^ = 6.2, J^^. = 7.7 Hz, 1H, HI %
4.45 (m, IH, m X  3.98 (d, J=  2.6 Hz, IH, H4'), 3.63 (d, J =  12.0 Hz, IH, MS'), 3.25 (d, 
y=  11.7 Hz, IH, MS'), 2.64 (br, IH, OH), 2.26 (ddd, = 5.9, = 11.5, Jŷ y = 2.8 Hz,
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IH, H2'), 2.16 (m, IH, H2% 1.82 (d, 7=  0.7 Hz, 3H, C5-CHjX 1.08 (s, 9H,
13c NMR (50 MHz, CDCI3) 6 163.4 (C4), 1502 (C2), 136.8, 135.7,133.1, 130.1,
127.9,127.9 (A t and C6), 1 11.0 (C5), 87.7 (C4*), 86.9 (Cl"), 73.0 (C3’), 62.1 (C5% 40.3 
(C2-), 26.9 (C(CH3)3), 19.0 (CCCHg)]), 12.5 (C5-CH3).
2.5.16 Synthesis o f l,4-Anhydro-2-deoxy-D-eiyt/tro-pent-l-enitol (2a).^^
Prepared according to Method D from la (96 mg, 0.40 mmol) and (NH4)2S04
(0.157 g, 1.19 mmol) in 5 mL of HMDS. No extraction was performed and the product 
was isolated by alum ina flash chromatogr^hy (1:2 ether-hexanes) to yield a yellow oil 
(0.0367 g, 80%). TLC: R f 024  (1:2 ether-hexanes); CIMS (isobutane) 117.1 (M + H)+; 
IH NMR (250 MHz, CDCI3) Ô 6.49 (d, Jm  = 2.3 Hz, IH, HI), 5.02 ( t,J=  2.4 Hz, IH, 
H2), 4.81 (m, 1H, H3), 4.31 (dt, J  = 2.5,6.5 Hz, 1H, H4), 3.65 (dd, J  = 5.9, 10.7 Hz,
IH, H5), 3.43 (dd, J=  6.8, 10.7 Hz, IH, H5). NMR (50 MHz, CD3OD) Ô 150.55 
(Cl), 104.27 (C2), 90.57 (C3), 76.08 (C4), 63.27 (C5).
2.5.17 Synthesis of l,4-Anhydro-5-0-(/err-batyldimethylsilyl)-2-deoxy-D-efylAro- 
pent-l-enitol (2b).22
Prepared according to Method D from lb (0.502 g, 1.41 mmol), HMDS (7 mL,
33.2 mmol), and (NH4)2S04 (0.196 g, 1.48 mmol). The product was purified by 
alumina flash chromatography (1:2 ether-hexanes) to yield a yellow oil (0.24 g , 74%). 
TLC: ^/0.98 (9:1 CHzClj-EtOAc); CIMS (NH3) 230.2 (M + H)+, 247.2 (M + NH»)̂ ;
•H NMR(250 MHz, CDCI3) Ô 6.53 (d, = 2.36 Hz, IH, HI), 5.14 (t, J  = 2.9 Hz, IH,
H2), 4.78 (br, IH, H3), 4.33 (dt, = 5.8, ̂ 3  =2.9 Hz, IH, H4), 3.71 (dd, = 10.7,
= 5.8 Hz, IH, H5), 3.51 (m, IH, H5), 1.60 (br, IH, OH), 0.89 (s, 9H, C(CH3)3),
0.07,0.06 (2s, 6H, S1-CH3 ). ‘^C NMR (62.9 MHz, CDCI3) 6 150.11 (Cl), 103.11 (C2),
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89.31 (C3), 75.67 (C4), 62.90 (C5), 25.83 (C(CH3)3), 18.29 (C(CH3)3), -5.36 (Si- 
CH3).
2^.18 Synthesis of l,4-Anhydro-S-0-(tleft^butyid:phenylsUyi)-2-deo:qr-D-gfythro- 
pent-l-enitol (2c).24
Prepared according to Method D from Ic (0.302 g, 0.63 mmol), HMDS (1 mL,
4.74 mmol), and (NH4)2S04 (0.350 g, 2.65 mmol). The product was purified by 
alumina flash chromatography (1:2 ether-hexanes) to yield a yellow oil (0.204 g, 91%). 
TLC: RfQJ9 (1:2 ether-hexanes); IH NMR (250 MHz, CDCI3) 5 7.77-7.74 (m, 4H,
Ar), 7.51-7.40 (m, 7H, Ar), 6.56 (d, J ^ =  2.6 Hz, IH, HI), 5.10 (t, J=  2.8 Hz, IH, H2),
5.04 (m, IH, H3), 4.45 (dt, = 2.4, ̂ ^5 = 5.2 Hz, IH, H4), 3.80 (dd, Jŷ  ̂= 5.0, 
^ 5=10.8 Hz, IH, H5), 3.70 (dd, = 5.8, = 10.7 Hz, IH, H5), 1.11 (s, 9H,
C(CH3)3). 13C NMR (62.9 MHz, CDCI3) 6 149.38 (Cl), 135.62, 134.0, 133.34,
129.73,127.71 (Ar), 103.29 (C2), 88.80 (C3), 75.73 (C4), 63.66 (C5), 26.81 
(C(CH3)3), 19.29 (C(CH3)3).
2,5.19 Synthesis of l,4-Anhydro-5-0^p-toluoyl)-2-deoxy-D-erytAm-pent-l-enitol 
(2d).
Prepared according to Method D from Id (0.0369 g, 0.102 mmol), HMDS (1 
mL, 4.74 mmol), and (NH4)2S04 (0.3 g, 2.3 mmol). The product was purified by 
alumina flash chromatography (1:2 ether-hexanes) to yield a clear oil (0.012 g, 52%). 
TLC: R f 0.67 (1:2 ether-hexanes); HR-FABMS (MNBA) theoretical (M + H)^
235.0970. Found: 234.0948; ‘H NMR (250 MHz, CDCI3) 6 7.96, (d, = 8.47 Hz, 2H,
Ar), 7.20 (d, = 8.2 Hz, 2H, Ar), 6.49 (d, = 2.0 Hz, IH, HI), 4.95 (t, J =  2.74 Hz,
IH, H2), 4.87 (m, IH, H3), 4.70 (m, IH, H4), 3.99 (m, 2H, HS), 2.41 (s, 3H, Ar-CH3 ).
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13C NMR (50 MHz CDCI3) 5 165.87 (C(0)-Ar), 149.06 (Cl), 143.34 (C(O)-Ar),
129.38,128.74 (Ar), 127.35 (Ar-CHs), 103.09 (C2), 86.01 (C3), 76.77 (C4), 63.68 
(C5), 2128 (tol-CHs). Anal. Calcd for C,3H,404: C 66.66, H 6.02. Found: C 66.58, H 
6.05.
2.520 Synthesis of l,4-Anhydro-3,5-bis-0-(teit-butyldiniethyIsUyl)-2-deoxy-D- 
erytbro-pent-l-emitol (2e).24
Prepared according to Method D from le (1.055 g, 2.24 mmol) and (NH4)2S04
(0.61 g, 4.62 mmol) in 10 mL HMDS. Yielded a yellow oil (0.534 g, 69%) after
purification by alumina flash chromatography (1:2 ether-hexanes). TLC: RfO.%6 (1:2
CHiClz-EtOAc); «H NMR (300 MHz, CDCI3) 5 6.45 (d, = 2.6 Hz, IH, HI), 5.00 (t,
2.50 Hz, IH, H2), 4.87 (br, IH, H3), 4.28 (dt, = 2.7,^ 5  = 5.9 Hz, IH, H4), 3.69 
(dd,J„4 = 5.6,y„5 = 10.6 Hz, lH ,//5),3.50(dd,y„^ = 6.4,yH5= 10.6Hz, IH ,m ), 0.90, 
0.89 (2s, 18H, C(CH3) 3), 0.08, 0.06 (2s, 12H, Si-CH3 ). l^C NMR (75 MHz, CDCI3) 6
149.16 (Cl), 103.56 (C2), 89.14 (C3), 76.21 (C4), 63.00 (C5), 26.08,25.91 (C(CH3)s), 
18.57,18.27 (C(CHs)3), -4.06 (Si-CHs), -4.21 (Si-CHg), -5.12 (Si-CHg).
2.521 Synthesis of l,4-Anhydro-5-0-(/erf-bntyldimethylsUyI)-3-0-(^^'^~ 
butyidipbenylsifyl)-2-deoxy-D-eiyl‘/rro-pent-l-enito! (2b),^^
Prepared according to Method D from lb  (1.80 g, 3.03 mmol) and (NH4)2S04 
(0.55 g, 4.16 mmol). The product was purified by alumina flash chromatography (1:1 
ether-hexanes) to yield a yellow oil (1.12 g, 79%). TLC: Rf 0.12 (1:2 ether-hexanes); 
CIMS (NH3) 469.3 (M + H)+, 486.3 (M + NH4)+; ‘H NMR (200 MHz, CDCI3) Ô 7.57-
7.49 (m, 4H, Ar), 7.23-7.19 (m, 6H, Ar), 6.30 (br, IH, HI), 4.86 (m, 2H, H2 andH3),
4.23 (br, IH, H4), 3.61 (dd, = 5.2, = 10.9 Hz, IH, H5), 3.51 (dd, = 5.2, =
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10.9 Hz, IH, H5), 0.94,0.76 (2s, 18H, C(CH3) 3 % -0.07 (s, 6H, Si-CH3 ). l^C NMR (50 
MHz, CDCI3) S 149.19 (Cl), 135.62,134.95,133.32,129.78,127.76,127.54 (Ar),
103.48 (C2), 89.04 (C3), 76.13 (C4), 63.73 (C5), 26.87,25.95 (C(CH3)3), 19.30, 18.06 
(C(CH3)3), -4.09 (Si-CHs), -4.29 (Si-CHs).
2.5.22 Synthesis of l,4-Anhydro-3-f>-(/ert-biityldlmethylsiiyl)-S-f^/err- 
butyldiphenybifyI)-2-deo]i^-D-efythiv-pent-l -enitol (2j).
Prepared according to Method D from I j  (0.72 g, 1.21 mmol) and (NH4)2S04
(0.60 g, 4.54 mmol). The product was purified by alumina flash chromatography to
yield a yellow oil (0.337 g, 59%). TLC: RfQ.19 (1:2 EtOAc-hexanes); HR-FABMS
(MNBA) theoretical (M - H)+ 467.2438. Found: 467.2430; >H NMR (250 MHz, 
CDCI3) Ô 7.72-7.66 (m, 4H, A r\ 7.46-7.37 (m, 6H, Ar), 6.52 (d, = 2.6 Hz, IH, H l\
5.06 (m, IH, H2), 4.99 (m, IH, H 3\ 4.38 (dt, = 3.1, = 5.1 Hz, IH, H4), 3.74 (dd,
= 5.5, = 10.9 Hz, IH, //5), 3.67 (dd, = 5.2, = 10.8 Hz, IH, H5), 1.09,
0.91 (2s, 18H, C(CH3)3 ), 0.01 (s, 6H, Si-CH3 ). NMR (50 MHz, CDCI3) S 149.12 
(Cl), 135.60,129.66, 127.65 (Ar), 103.47 (C2), 89.01 (C3), 76.01 (C4), 63.67 (C5), 
25.84,25.66 (C(CHs)s), 19.22 (C(CHs)3), -4.22, -4.41 (Si-CHs). Anal. Calcd for 
C27H4o03Si2: C 69.18, H 8.60. Found: C 68.91, H 8.77.
2.5.23 Synthesis of l,4-Anhydro-3-0-(/ert-batyldimethylsilyl)-5-0-(p-toluoyi)-2- 
deoxy-D-eiy/Aro-pent-l-enitol (21).
Prepared according to Method D from II (0.114 g, 0.24 mmol) and (NH4)2S04
(0.210 g, 1.59 mmol). A yellow oil (0.062 g, 74%) was obtained after purification by
alumina flash chromatogr^hy. TLC: RfQXl (1:2 EtOAc-hexanes); HR-FABMS
(MNBA) theoretical (M + H)"̂  349.1835. Found: 349.1830; ‘H NMR (250 MHz,
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CDCls) 6 7.97, (d, ,(^=8.1 Hz, 2H, Ar), 7.28 (d, = 9.6 Hz, 2H, Ar), 6.58 (d, = 2.6
Hz, IH, i/7), 5.25 (t, y  = 2.5 Hz, IH, ff2), 5.05 (m, IH, ffJ), 4.74 (dt, J=  2.9,5.9 Hz, 
IH, H4), 4.48 (d, = 5.9 Hz, 2H, H5), 2.44 (s, 3H, Ar-CHj), 0.92 (s, 9H, C(CH3)3\
0.08 (s, 6H, Si-CH3 ). NMR (50 MHz CDCI3) Ô 166.38 (C(O)-Ar), 149.06 (Cl),
143.82 (C(O)-Ar), 129.74,129.06 (Ar), 126.98 (Ar-CHs), 103.57 (C2), 86.33 (C3),
76.35 (C4), 64.10 (C5), 25.77 (C(CH3)3), 21.62 (tol-CHs), 18.01 (C(CH3)3), -4.30, -
4.48 (Si-CHs). Anal. Calcd for Ci9H2g04Si: C 65.48, H 8.10. Found: C 65.63, H 8.23.
2.524 Synthesis of l,4-Anhydro-2-deoxy-3'-0-(/eit-butyIdiphenylsifyl)-5*-0-</7- 
toIuoyl)-D-eiyl!frro-pent-l-enitol (2m).
Prepared according to Method D from Im (1.26 g, 2.10 mmol) and (NH|)2S04
(0.708 g, 5.36 mmol). A yellow oil (0.93 g, 94%) was obtained after purification by
alumina flash chromatography (EtOAc). TLC: 7^0.88 (1:2 EtOAc-hexanes); HR-
FABMS (MNBA) theoretical (M + H)+ 473.2148. Found: 473.2148; iH NMR (200 
MHz, CDCI3) 6 7.83 (d, = 7.9 Hz, 2H, Ar), 7.68-7.65 (m, 4H, Ar), 7.41-7.34 (m, 6H,
Ar), ( 7.20 (d, = 7.9,2H, Ar), 6.46 (d, = 2.9 Hz, IH, HI), 4.93 (t, J =  2.6 Hz, IH,
772), 4.85 (br, IH, 773), 4.68 (br, IH, H4), 3.99-3.94 (m, 2H, 775), 2.40 (s, 3H, Ar-CHs),
1.05 (s, 9H, C(CH3) 3). l^C NMR (50 MHz, CDCI3) 8 165.27 (C(O)-Ar), 149.14 (Cl),
143.74 (C(0)-Ar), 135.74,134.94, 129.92,129.81,129.25,129.04,127.84,127.70 
(Ar), 127.02 (Ar-CH3), 103.46 (C2), 86.36 (C3) 77.22 (C4), 64.06 (C5), 26.86 
(C(CH3)3), 19.04 (C(CH3)3). Anal. Calcd for Cz9H3z04Si: C 73.70, H 6.83. Found: C 
73.82, H 6.63.
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Synthesis of l,4-Anhydro>3-0-(/erf-balyldlniethylsiIyI)-2-deoxy-D-«yl‘A/’o- 
pent-l-enitol (2n).36
Prepared according to Method D from In  (0.1607 g, 0.45 mmol) and (NH4>2S04 
(0.304 g, 2.30 mmol). Alumina flash chromatography yielded a yellow oil (0.0375 g, 
36%). TLC: Rf 0.76 (1:2 EtOAc-hexanes). NMR (200 MHz, CDCI3) 5 6.47 (dd, 
Jh2 = 2.5 Hz, IH, H l\  5.01 (t, J=  2.5 Hz, IH, H 2\ 4.81 (t,7  = 2.3, IH, H3), 4.30 (dt, J  
= 2.7,9.1 Hz, IH ,7/4),3.65(dd,7H4 = 6.3, 7H5= 10.7Hz, lH ,/fJ),3.44(dd,7H4= 6.6, 
7h5 = 10.7 Hz, IH, H5), 0.89 (s, 9H, C(C%)j), 0.13 (s, 6H, S1-CH3). NMR (50 
MHz, C D C I3 ) S 148.87 (Cl), 103.38 (C2), 88.84 (C3), 76.09 (C4), 62.16 (C5), 25.89 
(C (C H 3 )3 ) , 18.13 (C(CH3)3), -4.33 (Si-CHs).
2,5.26 Synthesis of l,4-Anhydro-3-0-(ISert-baty!diphenybilyi)-2-deoxy-D-eiytftro- 
pent-l-enitol (2o).24’̂ 5
Prepared according to Method D from lo  (0.180 g, 0.37 mmol) and (NH4)2S04 
(0.245 g, 1.86 mmol). The product was purified using alumina flash chromatography to 
yield a yellow oil (0.105 g, 79%). TLC: 7^0.90 (1:2 EtOAc-hexanes); *H NMR (250 
MHz, C D C I3 ) 5 7.76-7.66 (m, 4H, A r\ 7.46-7.38 (m, 6H, Ar), 6.45 (d, 7h2 = 2.5 Hz, IH, 
7/7), 4.87 (t,7=  2.7 Hz, IH, 7/2), 4.78 (t, 7 =  2.5, IH, 7/i), 4.53-4.47 (m, IH, 7/4), 3.41 
(dd,7H4 = 7.0,7h5 = 10.8 Hz, IH, 7/5), 3.26 (dd,7H4 = 5.1,7hs = 10.8 Hz, IH, 7/5), 1.10 
(s, 9H, C(CHs)3). 13c NMR (50 MHz, CDCI3) 5 148.96 (Cl), 135.80,135.24, 134.23, 
129.63,127.70 (Ar), 103.33 (C2), 89.14 (C3), 76.37 (C4), 62.40 (C5), 26.57 (C(CH3)3),
19.02 (C(CH3)3).
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Universal nucleosides have been of great interest recently because of their ability 
to pair with any of the four naturally occurring nucleosides. This allows them to be 
inserted into ambiguous positions in DNA templates or primers. Through the use of 
variable hydrogen bonding patterns or relying solely on base stacking interactions, they 
can impart a greater stability to a DNA duplex than can be achieved by normal base pair
mismatches.
One use of universal nucleosides is in the ambiguous third position of DNA 
primers. Primers are necessary in extension reactions such as Polymerase Chain 
Reactions (PGR) and Sanger dideoxysequencing. In these reactions, the DNA strand of 
interest (to copy or to sequence) is called the template. To this template, the primer, a 
short section of DNA complementary to the template, is hybridized. Using the primer,
an entire strand of DNA, complementary to the template, can be generated via PCR.̂  
Using the same type of extension reactions, while providing a portion of 
dideoxynucleotides, generates DNA strands with a variety of lengths. When the 
difference in length is one base, the identity of that base can be disclosed by gel 
separation.4'5
In order to utilize any of these types of extension reactions, a primer 
complementary to the template must be generated, therefore, the sequence of the portion 
of the template where the primer will be attached must be known. This can be
41
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determined by sequencing the encoded protein. A group of three nucleotides (a codon) 
codes for the production of a specific amino acid in a protein. However, each amino 
acid can be generated by several different codons which generally differ in the third
position.^ This can be seen in Figure 3.1. The question maries are the unknown 
positions and the Xs are the universal bases that are incorporated into the primer versus 
the ambiguous positions. Thus the sequence of the primer is ambiguous in every third
position, but a universal nucleotide can be inserted into the ambiguous positions. ̂  ̂
5» -
X c T X G T X
G G 9 A T 9 G T 9 G A 9 C A 9 - 3’
Figure 3.1. Diagram of the use of universal bases in ambiguous positions in 
primers.
Another use of modified nucleotides is in the detection of minute amounts (1 in 
10^ of point mutations in gene sequences (Figure 3.2). To accomplish this, normal 
DNA corresponding to the mutation is converted to a restriction enzyme site. After
PCR amplification,^ digestion with the restriction enzyme removes the modified normal 
strand thereby selectively enhancing the mutant sequence.̂  Conversion of the normal 
strand to a restriction site is accomplish through the use of base transposing agents. 
These agents are modified nucleotides that pair to one or more of the natural
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Figure 3.2 Amplification of mutant DNA using PCR and restriction endonucleases
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rounds of PCR as demonstrated in Figure 3% In this example, the normal to mutant 
strands start out in a one to one ratio. They are first denatured and a primer is attached 
(Figure 3.2, step 1). Both of the primers of the contain a base transposing agent on the 
3' end. The primers are extended with a polymerase agent (Figure 3.2, step 2). In this 
example the base transposing agent is designed to insert an “A” across fium it in the 
PCR process. The duplexes are again denatured (Figure 3.2 step 3), and a primer is 
attached to the newly made strand. The primer is again extended with a polymerase 
agent (Figure 3.2, step 4). The duplexes are now in a two to two ratio (the original 
strands and modified strands are counted together). The entire process is repeated 
(Figure 3.2, step 4) to give a three to three ratio. The duplexes are subjected to a 
restriction engine partial to the normal strands (Figure 3.2, step 5). The normal strands 
are removed leaving the mutant to normal in a three to one ratio.
3,2 Specific Proposal
The preparation of C-nucleosides is of intense interest because of their potential
anti-viral and anti-tumor activity^» ̂ 0 and their use as novel base pairing moieties in 
oligonucleotides. 11 -14 jh e  nucleoside analogue 5-(2'-deoxy-|3-D-ribofuranosyl)-2- 
hydroxypyrimidone (Figure 3.3,1) is o f additional interest because it is a C-nucleoside, 
meaning the bond firom the sugar to the base is a C-C bond rather then a C-N bond.
This nucleoside was designed to fimction as a base transposing agent. The base could 
potentially exist in two tautomers as shown in Figure 3.3. Depending on the tautomer 
the hydrogen bonding pattern of the modified nucleoside could mimic a T or a C. This 
could allow it to fimction as a base transposing agent






Figure 33. Target C-nucIeoside
The approach we chose was based on the path advocated by Daves et a/. ̂ 8-23 
For this method the pyrimidone nucleoside 1 is generated by Pd(0) coupling of an 
iodinated pyrimidone ring to a silyl protected glycal (Scheme 3.1 ) followed by 
deprotection with tetrabutylammonium fluoride and treatment with sodium 
triacetoxyborohydride in acetic acid.
O N ^ N H
R O ^  _ U p . tetrabutyl h O- ^  .
'  N NH ™ o T  ammonium flouride triacetoxybo^ydride 1
/ /  +  (I J  Y  7  ► \  /  inacedcacid
OR' VI
Scheme 3.1 Proposed synthesis of 5-(2'-deoxy-P-D>ribofaranosyl)-2- 
hydroxypyrimldone
33  Coupling reactions
In addition to generating the glycal (described in Chapter 2), the synthesis of 5- 
iodopyrimidone (Scheme 3.2) was required for the palladium coupling reaction. This 
was accomplished by generating 2-hydroxypyrimidine hydrochloride (2) by the known 
method of treating urea and tetramethoxypropane with HCl in dry methanol (HCl, 
CH3OH, reflux, Ih. (78%)).24 It was converted to 5-iodopyrimidone (3) by iodination




^   HCl______ ^  N NH A^-lcxlosuccinimit^ N NH
Il O  O
H;N NH; X    „ A
H jC O ^ ^ O C H ; 
H3C O  O C H 3
1! ^  W
I
Scheme 3^ Synthesis of S-iodopyrimidone
with A^-iodosuccinimide in the absence of light and moisture (iV-iodosuccinimide in 
DMF, dark, room temperature, 24 hs. (82%)).25
The coupling reaction of 5-iodopyrimidone (3) to a variety of glycals (Scheme 
3.1) was tried utilizing a variety of conditions. The Pd(0) was generated in situ from 
Pd(0 Ac)2 using tri-iV-butylamine or added as Pd(0) attached to a resin. The coupling 
was attempted in the presence and the absence of a ligand (triphenylarsine) with the 
Pd(OAc)z being complexed to the ligand prior to reaction in some cases. It was also 
once attempted in the presence of sodium acetate. In all cases the solvent was DMF, 
and the reaction was heated to 75-I00‘’C. A coupling of the base to dihydropyran was 
attempted as a control with similar varieties of conditions. In all cases no product was 
formed. However the coupling of bromobenzene to dihydropyran worked well. Daves
et then reported that coupling reactions were found to fail in the presence of an 
amide. To compensate for this, 5-iodopyrimidone (3) was protected with a TMS group 
or a dihydropyran group. Again a variety of coupling conditions were utilized but no 
product was generated. The TMS group speared unstable and the dihydropyran group 
created added difficulty in characterization. 5-Iodopyrimidone was then converted to 5- 
iodo-2-methoxypyrimidine (64%) by treatment with phosphorus oxychloride (Scheme 
3.3) and diethylaniline at reflux for 24 hours to yield 5-iodo-2-chloropyrimidine (4) in
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63% yield. This was immediately treated with sodium methoxide as shown in Scheme
3.3 (Na, CH3OH, room temperature, 2 h (5 ,95%)).22 The coupling reaction was tried 
utilizing the protected pyrimidine 5 under a variety of conditions. Pd(OAc)2 was again
Cl




Scheme 33 Conversion of 5-modopyrhnidone to 5-iodo-2-methoxypyrimldlne
used as the Pd(0) source but it was reduced using triethylamine. Occasionally sodium 
hydrogen carbonate was added to the mixture. The coupling was attempted several 
times without ligand using DMF or acetonitrile as the solvent. It was also attempted 
with PPhs (attached to a resin) as the ligand. Again, all attempts failed.
Coleman ef a/. 26 recently published the synthesis of a C-nucleoside using a 
palladium-catalyzed Heck coupling strategy. In this publication th^r report many of the 
same problems we encountered. There does not seem to be a standard set of reaction 
conditions for this type of reaction, or even for a particular group of compounds used in 
this reaction. Many different reaction conditions have to be varied (choice of ligand, 
solvent, base, choice of glycal, source of palladium) in the hopes of determining a set of 
conditions that would promote the reaction. Some conditions that we found to be 
ineffective were also found to be ineffective by Coleman et al. 26 Although the reaction 
theoretically needs 0.1 equivalent of palladium it seems to progress better with 0.5 
equivalents. The use of triethylamine as the base is often ineffective and should be 
replaced with sodium hydrogen carbonate.
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One reason for the failure was thought to be that 5-iodo-2-methoxypyrimidine
(5) was too reactive, because the main products formed seemed to be reduction of the 
pyrimidine and dimers of pyrimidines. This indicated we were forming the requisite 
insertion of palladium into the Ar-I bond but the reaction was proceeding on along an 
unproductive pathway. Therefore 5-bromo-2-methoxypyrimidine was tried instead. It 
was ^thesized by treating 2-hydroxypyrmidinone (Scheme 3.4,2) with Brz in water at 
room temperature for 24 hours giving 5-bromopyrimidone (6) in 55% yield. This was
o »  ^
^  Brz/HjO n ^ n H Phosphorous oxycfaloride N N sodium methoxide N
2  ^  diethylaniline ^
^  Br Br
6 7 8
Scheme 3.4 Synthesis of 5-bromo-2-methoxypyriniidlne
then converted to 5-bromo-2-chloropyrimidine (7, 70%) and then to 5-bromo-2- 
methoxypyrimidine (8, 95%) using the same method described above. The coupling 
reactions were tried again without success.
Cabri et alX^ reported the possibility of mechanisms based on two reaction 
pathways (Scheme 3.5) which were supported by the results of Coleman et 
Pathway A involves coordination of the olefin via the dissociation of one neutral ligand. 
This is the pathway followed by reactions involving aryl halides. Historically this was 
the proposed form of the reaction. A modification of the reaction, using triflate as the 
leaving group changes the pathway to B. In this pathway the coordination of the olefin 
proceeds via dissociation o f the anionic ligand because o f the very weak nucleophilici^ 
of triflate. Therefore, pathway B is promoted by the use o f bidentate ligands such as




















Scheme 3^ Pd coupling mechanism proposed by Cabri
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l^-bis(diphenylphosphino)propane (DPPP) whereas path A is slowed. In addition 
pathway B is better for electron rich double bonds. Therefore, a possibility is the use of 
5-trifIate-2-niethoxypyriinidine with DPPP as the ligand.
Another reason for difficulty is that the glycals are rather unstable, and are 
possibly being destroyed under the reaction conditions. However 5-0-toluoylglyca!s 
tend to be rather more stable than silyl protected glycals, but coupling reactions utilizing 
these compounds were also unsuccessful.
3.4 Grignard Reactions
In light of the above results, preparation o f the pyrimidone nucleoside 1 was
attempted by Grignard reaction as demonstrated by Kool et in this method 1- 
chloro-2-deoxy-3,5-di-0 -/7-toluoyI-a-D-e7yrhro-pentosyI chloride is required rather then
a glycal. I t  is synthesized by the known literature p r e p a r a t i o n ^ ^  of treating 2- 
deoxyribose (Scheme3.6,9) with HCl in methanol followed by protection withp-toluoyl
TolO^ Q  TolO^\ y I. HCl in_methanol_________ ^   ̂ '^ O M e
r r  2. p-toluoylchloride in pyridine yJ  “  Acetic Acid \ _ / c i
^  5 tôI
10 „
Scheme 3.6 Synthesis o f 33-^bistoIaoyl-l-chlororibose
chloride in pyridine to give the 3,5-D-bistoluoylprotected sugar (Scheme 3.6,10,99%). 
The methoxy group is then exchanged for a chlorine using HCl in acetic acid to yield 
the 3,5-O-bistoluoyl-l -chlororibose (11,60%).
S-Iodo-2-methoxypyrimidine (3) and 5-bromo-2-methoxypyrimidine (8) were 
converted to the Grignard by treatment with magnesium and iodine in tetrahydrofuran
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(Scheme 3.7).^ The chlorosugar 11 was then added, and the solution was stirred 




Scheme 3.7 Grignard coupling o f S-iodo-2-metho^q*yrim:dine to chlorosugar
but all attempts were unsuccessful. The major product appeared to be (by NMR) the 
addition of the pyrimidine to the toluoyl protecting group.
3.5 Conclusions
Synthesis of the C-nucleoside 5-(2'-deoxy-P-D-ribofuranosyl)-2- 
hydroxypyrimidine has been hampered by a number of synthetic hurdles. The starting 
materials were difScult to prepare and were often stable for only short periods of time. 
In addition both the Pd coupling procedure and the Grignard procedure yielded reaction 
mixtures that were a complex mixture of numerous products. Traces of the desired 
product were occasionally seen, but it was never isolated. One problem is the 
possibility that the product is acid labile and does not survive the isolation techniques. 
The nucleoside is unlikely to be generated by a coupling procedure that unites a pre­
formed sugar system to a base, however it is being investigated by the method of 
construction of the base on the sugar.
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3.6 Experimental
3.6.1 Synthesis o f 2-Hydroxypyrimidiae Hydrochloride (2).24
A 3 liter flask was charged with one liter o f dry methanol (791 g, 24.68 mol).
The methanol was saturated with HCl by bubbling gas through it for 20 minutes at 0°C. 
Urea (182.34 g, 3.04 mol) was dissolved in the solution and then 1,13,3-tetra 
methoxypropane was added dropwise. The mixture was warmed to room temperature 
and then refluxed for one hour. Yellow crystals formed and were filtered and dried over 
NaOH in vacuo. Yield was 312.50 grams (78%). EIMS 97.1 (M + H)+; IR NMR (300 
MHz, DMSO) 8 14.14 (b, IH, NH), 8.79 (d, IH, H4 or H6 , J hs= 5 .8 ) ,  6.82 (t, IH, H5. 
J h4 = 5 .8 0 ) .  1 3 c  NMR (75 MHz, DMSO) 8 159.32 (C4, C6), 147.99 (C2), 104.30 (05).
3.6.2 Synthesis o f 5-Iodopyrimidone (3).^^
2-Hydroxypyrimidine hydrochloride (11.98 g, 0.09 mol) was introduced to a 
dried flask under Ar. DMF (80 mL) was added and the flask was wrapped in aluminum 
foil to exclude light. N-iodosuccinimide (20.09 g) was added and the solution was 
stirred for 24 hours. The DMF was removed under vacuum and the solid was washed 
with ether and then with acetone to yield 16.52 grams (82% yield) of a bright yellow 
solid. m.p. 240 ®C, EIMS 220.9 (M-H)', ‘H NMR (250 MHz, DMSO) 8 12.15 (b, IH, 
NH), 8.45 (s, 2H, H4 andH 6). "C NMR (62.5 MHz, DMSO) 161.57 (C2), 155.83 (C4 
and C6), 85.53 (C5).
3.6.3 Synthesis o f 2-Chloro-5-Iodopyrimidine(4).^^
A dried flask was charged with 5-iodopyrimidin-2-one (1.58 g, 7.11 mmol). 
Phosphorus oxychloride (10 mL) was added and then diethylaniline was added slowly.
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The solution was refluxed for 12 hours. It was cooled to room temperature and poured 
over ice (300 mL) and left for 15 minutes. The product was extracted with ether (3x 75 
mL) and washed with saturated aqueous NaHCCh and then with distilled water. The 
ether layer was dried with sodium sulfate and the solvent was removed under reduced 
pressure to yield 1.15 grams of oil (63% yield). EIMS 240.9 (M+H)^; NMR (250 
MHz, CDCI3) 6 8.81 (s, H4 and H6 ).
3.6.4 Synthesis of S-Iodo-l-methoxypyrimidine (5).^^
2-Chloro-5-Iodopyrimidine (1.05 g, 4.4 mmol) was added to a dried flask. Dry 
methanol (4.5 mL) was added to the flask. Sodium metal (0.17g, 7.39 mmol) was 
dissolved in 5.5 mL of dry methanol and the solution was added dropwise to the 2~ 
Chloro-5-Iodopyrimidine solution. The solution was allowed to stir for two hours and 
then the methanol was evaporated under reduced pressure. The product was partitioned 
between water and chloroform. The chloroform layer was dried with sodium sulfate, 
partially evaporated and recrystallized yielding 0.983 g of product (95% yield). Rf=
0.64 (1:2 ether/hexanes). 'H NMR (250 MHz, CDCI3) Ô 8.65 (s, 2H, H4 cmdH6 ), 3.99 
(s, 3H, OC//3). '̂ C NMR (75 MHz, CDCI3) Ô 164.07 (C2 and C4), 55.11 (OCH3).
3.6.5 Synthesis of S-Bromopyrimidone (6).^^
Distilled water (300 mL) was added to a liter flask. Bromine was added (0.435 
mL) and the solution was stirred until it was evenly distributed. 2-Hydroxypyrimidine 
hydrochloride (1.0064 g, 7.6 mmol) was added and the solution was left to stir for 24 
hours. The solution was periodically checked by NMR and more Brz was added as 
needed to drive the reaction to product (0.91 mL additional Br; was added). The water
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was driven off and the product recrystallized firom ethanol to yield 0.7288 g (55% yield). 
‘H NMR (200 MHz, DMSO) Ô 8.21 (s, H4 and H6 ).
3.6.6 Synthesis of 5-Bromo-2-methoxypyrimldme (8).^^
5-Bromo-2-chloropyrimidine (3.3811 g, 19.32 mmol) was added to a dried flask 
followed by POCI3 (20 mL). Diethylaniline was added (1 mL) and the solution was 
refluxed for 12 hours. It was then cooled to 0°C and quenched by pouring it onto ice. 
The product was extracted with dichloromethane. The organic layer was washed with 
NaHCO] until bubbling stopped. It was then washed with saturated brine and distilled 
water. It was dried with NazSO# and evaporated under reduced pressure to yield a 
yellowish syrup (3.63 g, 12.74 mmol) in 70 % yield. The 5-bromo-2-chloropyrimidine
(7) was then dried under high vacuum and dissolved in dry methanol (30 mL). Another 
20 mL of dry methanol was added to an addition funnel and sodium metal was added 
(0.3 8g, 16.53 mmol). When it had reacted the solution was added dropwise. NMR on 
an aliquot showed reaction had not finished after several hours so 10 mL of CH3OH and 
0.2 g of sodium were added to the addition funnel and then dropped into the solution. 
The solution was left to stir for 2 hours and then the methanol was removed under 
reduced pressure. The product was extracted firom water with ether. The organic layer 
was washed with saturated NaHC03 and distilled water. The ether was partially 
evaporated under reduced pressure and the product was recystallized to yield 0.5149 g 
(3.198 mmol). *H NMR (250 MHz, CDCI3) 5 8.35 (s, 2H, H4 andH6), 4.02 (s, 3H, 
OCH3).
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3.6.7 Synthesis of l-M ethoxy-2^bis-0-tolaoylribose (10).^^
2-Deoxyribose (13.6 g, 0.1 mol) was dissolved in dry methanol (240 mL). A 
solution of 1% HCl in CH3OH was added and the solution was stirred for 15 minutes. 
Silver carbonate (3.5 g, 12.69 mmol) was added quickly with vigorous stirring for 5 
minutes. The mixture was filtered and the resulting clear solution was evaporated under 
reduced pressure to give a clear syrup. Residual methanol was removed by co- 
ev^x>ration with pyridine. The syrup was then dissolved in dry pyridine (100 mL) and 
cooled to 0®C. p-Toluoyl chloride (34g, 022 mol) was added dropwise over 2 hours. 
The solution was allowed to warm to room temperature and stirred under nitrogen 
overnight. Distilled water was added (300 mL) and the product was extracted with ether 
(3 X 200 mL). The organic layer was washed with distilled water, 2N H2SO4 and 
saturated KHCO3. It was dried with Na2S04 and evaporated under reduced pressure to 
give a yellow syrup (38.3 g, 0.099 mol) in 99% yield. NMR (300 Mhz, CDCI3) 5 
7.95 (m, 2H, Ar), 7.29 (m, 2H, Ar), 5.60 (m, 2H, H2), 5.40 (m, 1 H, H2), 5.19 (m, 2H, 
HlandH4), 4.54 (m, 2H, H5), 3.42 (s, 3H, OC//3), 2.39 (s, 6H, CH3).
3.6.8 Synthesis of l-C hloro-3^bis-0-tolaoylribose (11).
1 -Methoxy-3,5-bis-O-toluoylribose (4.11 g, 0.011 mmol) was dried in a flask 
under high vacuum for 8 hours. Cool glacial acetic acid (5 mL) was added. The 
reaction was kept at 10®C and HCl saturated acetic acid (8.8 mL) was added. HCl gas 
was then bubbled through until a white precipitate started to form. It was stirred for 5 
more minutes and then it was filtered, washed with dry ether and dried in vacuo over 
P 2 O 5 .  The yield was 2.498 g of a white solid (60 %). *H NMR (250 MHz, CDCI3) 6
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7.91 (m, 2H, A r\ 7.25 (m, 2H, Ar), 6.47 (d, IH, H l\  5.55 (m, IH, H3), 4.85 (m, 2H, 
H2), 4.63 (m, 3H, H4 ondHS), 2.42 (s, 3H, C/fj), 2.41 (s, 3H, C/fj).
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Chapter 4
Non-Hydrogen-Bonding Nncleobase Analogs: Synthesis and Thermo<tynaniic 
Analysû of Ol^onncleotides Containing 4-Snbstitated-PyrazoIe Nucleotides
4.1 Introduction
The thermo(fynamic stability of the DNA double helix has been under intense 
investigation since its discovery by Watson and Crick in 1953. ̂  The relative 
importance of interactions giving rise to that stability such as, base-base hydrogen 
bonding, “base stacking” and base pair geometry has been the subject of much research. 
However, the relative importance of each contribution is not fully understood. It is 
gmerally accepted that H-bonds between DNA molecules in aqueous environments can 
only partially account for duplex stabilization because of high dielectric constants of the
medium and competition for H-bonding with s o l v e n t . 2 > 3  Thus, the contribution to the 
duplex stability from “base-stacking” (the interaction between aromatic tc systems) may 
be roughly the same as from hydrogen bonding. It is estimated that base stacking and H 
bonding both contribute approximately 1 kcal/mol of free energy to the stability of the 
base pair.^’̂  It has been observed that free mononucleotides in aqueous solution tend to 
aggregate without hydrogen bonding (according to NMR). Consequently base stacking 
in DNA has become an area of much interest. However, there have been few studies to 
determine the factors contributing to 7C-ir interactions in the DNA structure.^ Theoretical 
studies have identified several contributing factors: solvophobic effects,^»^ van der 
Waals f o r c e s ^ - 10 and electrostatic e f f e c t s . ^ 1 2  Experimental studies that aid in
5 8
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determining the importance of each component would be useful in their own right and 
would aid in the design of biologically important molecules.
One way to investigate this is to incorporate non-hydrogen bonding nucleosides 
into a DNA double helix and determine the effect on the thermodynamic parameters. 
There have been several non-hydrogen bonding nucleosides incorporated into 
d u p l e x e s ,  13-18 however, one of the first examples of a series of non-hydrogen bonding 
nucleosides used to study base stacking experimentally was performed by Kool and
coworkers. 1  ̂ Following the work of Turner et al.^ they placed a series of modified 
nucleosides in a dangling position of a duplex to determine the effect on stability. The 
series of nucleosides ranged in size and polarity and were put on the end of a DNA 
duplex in a position that had no base pairing partner (5’-XCGCGCG-3’ was used as a 
self complementary strand where the modified bases (X) dangled off both ends without 
a pairing partner). They found that the nucleoside analogs that were larger and less 
polar increased the Tm the most.
Bergstrom et a/.20 investigated the importance of “base-stacking” by placing a 
series of nitrosubstitued azoles as well as some non-nitro containing controls into the 
core of a DNA duplex. They discovered that the role of the nitro group was extremely 
important in stabilization. They also discovered that a ring nitrogen capable of 
hydrogen bonding decreased the “universality” o f the nucleoside.
4,2 Design of Nacleosides
In an effort to determine the effect different sizes, stacking abilities and charge 
profiles would have on the stability of nucleosides we have synthesized and determined 
the thermodynamic properties of a series of non-hydrogen bonding nucleosides:
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l-(2’-<ieoxy-P-D-ribo£uranosyl)-4-iodopyrazoIe (Figure 4.1, a), l-(2’-deo3qr-P-D- 
ribofiiranosyl)-4-nitropyrazoie (Figure 4.1, b), l-(2’-deoxy-P-D-ribofiiranosyl)-4- 
propynylpyrazole (Figure 4.1, c), l-(2’-deoxy-P-D-ribofuranosyI)-4-(2-thia2oIyl) 









Figure 4.1 Structure of target non-hydrogen bonding nucleosides
Hunter et a/.21 studied the effects caused by sequence on DNA structure. 
Because the only difference in the sequence is the bases (the sugar-phosphate backbone 
is the same regardless of sequence), the differences must arise from differences in their 
interactions. The sequence effects are caused by four Q^ies of interactions; (1) steric 
interactions with the guanine amino group in the minor groove,^^ (2) steric interactions 
associated with the configuration of the step (interaction of two adjacent bases on a 
single DNA strand; purine-purine, purine-pyrimidine or pyriniidine-pyrirnidine),^^ (3) 
steric interactions of the thymidine methyl in the major groove, (4) electrostatic 
interactions associated with the molecular charge distributions of the A-T and C-G base 
pairs. Hunter et a/.^l found that for an AA/TT step the interaction was dominated by 
steric interactions because the A-T pair has no large regions of high charge densi^
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(Figure 4J2). The CC/GG step is dominated by electrostatic interactions because of the 
regions of high charge density (a center of positive charge over cytosine
±1 I  A 
R
Figure 4.2 Electronic charge distributions of natural nucleosides
and a negative charge one over guanine). This indicates that when there are large 
centers of charge the electrostatic interactions become increasingly more important.
Bergstrom and coworkers^^ studied a series of nitro substituted azoles to 
investigate the effect of electronic structure and heterocycle size on duplex stability. 
They discovered that the nitro group played an important role in stability, however in 
the absence of other groups the exact nature of the role of the substituent could not be 
determined. They also discovered that adding a ring nitrogen that could be involved in 
hydrogen bonding increased the specificity of the base.
Froehler et. a/.^4,25 found that substituting a propyne substituent onto the C-5 
position of cytosine and uridine increased the stability because of entropie factors 
caused by the hydrophobic chain displacing water. In addition the propyne unit 
probably allowed increased “base-stacking”. Froehler et al.^^ also found that a thiazole 
substituent increased the stability of a dC or a dG. The thiazoyl substituent was 
postulated to be planar with the heterocycle and to allow a larger area of delocalized tc 
electrons which would aid in base stacking.
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The pyrazole ring was chosen because utilizing a small ring size would 
decrease the likelihood of steric hindrance when placed versus one o f the purines. 
Bergstrom and coworkers^^»^^ synthesized one of the first non-hydrogen bonding 
nucleoside analogs that possessed some degree of stability, 3-nitropyrrole. The molecule 
was designed to mimic the electronic configuration ofp-nitroaniline, a know DNA 
intercalator and to be small enough to be incorporated versus purines without disrupting
H-bonding. Kool and cowoikers^^ also showed that breaking the hydrogen bonding of 
the nucleoside to solvent without replacing it with anything was thermodynamically 
unfavorable. Utilizing a smaller ring size would allow the incorporation of solvent 
molecules more easily if necessary. The use of iodo, nitro, propynyl and thiazolyl 
substituents would allow a variation in size and electronic charge distribution profile 
(Figure 4.3) that would lend insight into the roles they play in thermodynamic stability. 
The calculations were made using Huckel molecular orbital calculation in the Sybyl 
molecular modeling program.
Generally a broader tc cloud and one that has centers of charge or is relatively 
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Figure 43  Electronic charge distribution of bases
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heterocycle is changed from an iodo through nitro and propyne to a thiazoyl there would 
be an increase in the binding afBnhy in a duplex and therefore an increase in Tm.
4 ^  Synthesis of Nacleosides
4-Iodopyrazole nucleoside, 4-bromopyrazole nucleoside and 4-nitropyrazole 
nucleoside (2a-c) were synthesized by treating the appropriate pyrazole (4-iodopyrazole 
la , 4-bomopyrazole lb  or 4-nitropyrazole Ic) with NaH and then adding it to 3,5-Bis- 
O-^toluoyl-1 - c h l o r o - p - D - r i b o s e 2 0 * 2 7 , 2 8  in 7 2  % to 86% yields (Scheme 4.1). 4- 
iodopyrazole is commercially available but 4-nitropyrazole and 4-bromopyrazole were
X
X
I. NaH / /  V
,N// 'I  .    T d O -. ." N '"
H \  / Y ,  V—/  Pd(Cl2XPPh3)2











Scheme 4.1 Synthesis of pyrazole nucleosides
synthesized from pyrazole using fuming nitric acid/fuming sulfuric acid or bromine in 
water respectively. 4-Propynepyrazole nucleoside (2d) was made from 4-iodopyrazole 
nucleoside or 4-bromopyrazolenucleoside (2a or 2b) by treatment with propyne gas, 
Pd(Cl2)(PPh3)4,29,30 triethylamine and copper iodide in 96 % yield.
The toluoyl protected nucleosides (2a, c-e) were then deprotected by treatment 
with ammonia in methanol to give the 5'- and 3' free hydroxyls (Scheme 4.2,3a,c-e). A 
dimethoxytrityl (DMT) protecting group was introduced to the 5'- hydroxyl using
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2aX = I 
2cX = N02 
2dX = Propyne 
2e X= Thiazole
3aX = I 
3cX = NO,




4aX = I 
4cX = N02 








5aX = I 
5cX = N02 
5d X = Propyne 
5e X= Thiazole
Scheme 4.2 Conversion of pyrazole nucleosides to phosphoramidites
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diisopropylethylamine (DEEA), dimethylaminopyrinde (DMAP) and DMT-chloride in 
dichloromethane to give 4a,c-e. The nucleosides were then converted to the 
phosphoramidites (5a,c-e) by treatment with 2-cyanoethyl N ^ - 
diisopropylchlorophosphoramidite in pyridine and DIEA.^ ̂  The phosphoramidites 
were then incorporated into oligomers using standard solid phase chemistry.
4.4 Solid Phase DNA Synthesis
DNA synthesis is simple in concept A reactive 3'-phosphorus group of one 
nucleoside is coupled to the 5'-hydroxyl of another. Generally this is done using the 
phosphoramidite method^^ because of the efiBcient and rapid coupling and the stability
of the starting materials. It is usually performed on a solid support^^ (o minimize 
isolation and purification steps. An excess of reagents can be used and the product
purified by filtration. The solid support is a controlled-pore-glass (CFG) bead.^^ The 
first nucleoside comes attached to the CFG through a succinate ester linkage attached to 
a siloxane bond. The rest of the nucleosides are added by a repetition of the series: 
detritylation, coupling, coping and oxidation (Scheme 4.3).
The first step in the cycle is the removal of the DMT protecting group from the 
5'-hydroxyl (Scheme 4.3, Step 1). This is accomplished using trichloroacetic acid 
(TCA). This step is a reversible reaction (under anhydrous conditions) and is driven to 
completion by washing away the DMT cation. It yields the free 5'-hydroxyl, which is 
ready for coupling to the next phosphoramidite.
The phosphoramidites are protected nucleosides that are ready for solid phase 
coupling. They come with 4 protecting groups (Figure 4.4). There is a

























Scheme 43  Synthesis of DNA by the solid phase phosphoramidite method
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diisopropylamino on the 3'-trivalent phosphorus group^^ which is used in the coupling 
step. There is also a P-cyanoethyl group on the phosphorus which stays in place until 
the final deprotection at the end of the synthesis. It helps to prevent side reactions and 
aids in solubility. There is a DMT group on the 5 -hydroxyl and benzoyl(bz) or 
isobutyryl(ib) on the exocyclic amines of A, C and G. The coupling (Scheme 4.3, Step 
2) is accomplished by delivering the phosphoramidite (protected bases are indicated by 
B(P)) with the mild acid tetrazole (pKr=4.8). The tetrazole protonates the nitrogen of
the diisopropyl group vdiich is then displaced by the tetrazole.^b This intermediate is 
then used to make the intemucleotide phosphite bond with the 5'-hydroxyl.
The third step is capping (Scheme 4.3, Step 3). This step is not strictly essential 
but it serves to ease the purification of the final product. The coupling step is not 
quantitative. The capping step is used to prevent the unreacted sequences from reacting 
in future steps. This helps to keep failure sequences as short as possible which means 
they are easier to separate firom the completed product. It is accomplished by treatment 
with acetic anhydride and iV-methylimidazole which react to make a powerful acylating 
reagent. The last step in the cycle is to oxidize the phosphite triester (trivalent 
phosphorus) to a phosphate triester (pentavalent phosphorus) (Scheme 4.3, Step 4).
This is done at the end of each cycle because the phosphite is susceptible to acid and 
base cleavage. A mild oxidation is accomplished using iodine in a basic tetrahydrofuran 
(THF) solution in water.
After all o f the nucleosides are added, the sequences are cleaved from the 
support and the P-cyanoethyl groups on the phosphorus are removed by treatment with
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concentrated ammonium hydroxide at room temperature for 1 hour. The protecting 
groups on the exocyclic amines o f the bases are removed by treatment with concentrated 
ammonium hydroxide at 5S°C for 8 hours.
4.5 Sequences Used in Thermodynamic Mehing Studies
The four pyrazole nucleosides (3a,c-e) as well as 5-nitroindole for comparison 
were incorporated into two sequences. The first was a self-complementary sequence 
based on the Dickerson dodecamer (Figure 4.5). The modified oligomers were 
incorporated into the fourth position and each of A, C, G and T were incorporated into 
the complementary ninth position giving four different modified strands for each 
nucleoside analog. In addition four control duplexes were tested to ensure that results 
Modified Dickerson Dodecamer 5 -CGC XAA TTY GCG-3’
Controls
X= 2a,c-e and 5-nitroindole Y= A, C, G and T
5 -CGC AAA TTT GCG-3’
5 -CGC CAA TTG GCG-3’




5’-CGC TAA TTA GCG-3’
5’-CAA AAT GGT GGC CAA GT-3’
S’-ACT TGG CCA CCA TTT TG-3’
S’-CAA AAT GGT GGC XAA GT-3’
5’-CAA AAX GGX GGC XAA GT-3’
X= 2a,c-e and 5-nitroindole
Figure 4.5 Sequences used in thermodynamic studies
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were not merely sequence effects. The second sequence was the oligomer used by
Brown in his investigation o f the nitroindole series^ ̂  to allow an easier comparison to 
5-nitroindole. The same control was used as well as a sequence that incorporates the 
modified nucleobases in the thirteenth position fix>m the five prime end. Because a 
single modification can easily be accommodated in a DNA duplex a strand was made 
that incorporated modifications in the sixth, ninth and thirteenth positions (Figure 4.5). 
After purification and analysis (see Experimental) the oligomers were 
thermodynamically melted to determine their thermodynamic properties and calculated 
Tm at 15 pmol (Tables 4.1 and 4.2).
4.6 Thermodynamic Melting
Thermodynamic melting is the process of denaturing a DNA duplex by heating 
i t  In order to determine the thermodynamic properties of a duplex the absorbance at 
260 am is measured as the duplex is heated. As the duplex separates to the single 
strands and the bases unstack the absorbance increases in a phenomenon called 
hypochromicity. This can be seen in Figure 4.6. When the bases are in a stacked 
arrangement the interaction of the electron clouds causes a decreased absorption. This 
region is commonly called the “lower baseline”. As they unstack during the melting 
process the absorption increases until it reaches the “upper baseline”. The point where 
the melting has progressed 50 percent of the way is the melt temperature, Tm. The graph 
of the change in temperature versus the change in absorption is called the melting curve.
The thermodynamic results (Table 4.1 and Figure 4.7) show that the series of 
pyrazole nucleosides shows a relative increase in thermodynamic stability (based on
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Figure 4.6 Example of a meiting curve diagram at various concentrations 
(normalûed).
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
72




T .*C  






(kcal/mol a t 25*C)
T-A (Cent 1) 47.5 -72.5 -204 -3.8
G-C(Cont2) 58.8 -99.6 -290.4 -8.1
C-G(Cont3) 54.4 -72.4 -226.3 -4.9
A-T (Cent 4) 53.5 -82.8 -258.8 -5.7
5-mtroindoie-A 25.2 22.3 -39.3 -109.6 -6.6
5-nhroindole-C 30.6 28.2 -26.9 -66.4 -7.1
5-nitroindole-G 27.8 26.6 -29.1 -74.5 -6.9
5-nitroindole-T 38.4 15.1 -36.8 -96.0 -8.1
4-iodopyrazole-A 1 0 . 6 3 6 . 9 - 2 8 . 4 - 1 0 5 . 4 3 . 0
4-iodopyrazole-C 3 . 2 5 5 . 6 - 3 3 . 7 - 1 2 7 . 3 4 . 2
4-iodopyrazole-G 7 . 4 4 7 . 0 - 2 9 . 6 - 1 1 1 . 1 3 . 4
4-iodopyrazole-T 5 . 2 4 8 . 3 - 3 1 . 5 - 1 3 7 . 2 3 . 4
4-nitropyrazoIe-A 21.1 26.4 -49.7 -174.2 2.2
4-nitrcpyrazole-C 11.1 47.7 -37.5 -137.2 3.4
4-nitropyrazole-G 10.1 44.3 -33.1 -122.3 3.3
4-nitropyrazoIe-T 14.2 39.3 -37.5 -135.8 3.0
4-propynylpyrazoIe-A 21.9 25.6 -41.4 -145.7 2.0
4-propynyIpyrazoIe-C 5.8 53 -29.2 -110.1 3.6
4-propynylpyrazoIe-G 18.2 36.2 -53.7 -189.7 2.8
4-propynylpyrazoIe-T 9.3 44.2 -21.1 -80.2 2.8
4-thiazolylpyrazoIe-A 25.2 22.3 -46.2 -132.7 -6.6
4-thiazolylpyrazoIe-C 16.7 42.1 -32.8 -91.0 -5.6
4-thiazoIyIpyrazole-G 27.3 27.1 -34.2 -92.0 -6.8
4-thiazolylpyrazole-T 24.8 28.7 -48.8 -142.0 -6.5
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C om parison  o f  -A Tm for e a c h  a n a lo g  w ith  




bid lo N Pr Tz
Figure 4.7 Comparison of ATm for the modified nacleosides with each natural 
base
increasing Tm) as the substitutuents vary from iodo to nitro and propyne to thiazole. As 
expected the iodopyrazole was the least stable of the pyrazole nucleosides. For the two 
incorporations required of a self-complementary strand the stability dropped roughly 
20®C-40®C from that of the control. The nitro and propyne pyrazole nucleosides were 
more stable than the iodopyrazole but were similar in stability to each other contrary to 
expectations. The thiazole pyrazole nucleoside did show a substantial increase in Tm 
compared to the other three pyrazole nucleosides. It had a stability approaching that of 
5-nitroindole. 5-Nitroindole shows a preference for the pyrimidines (T then C) whereas 
the pyrazole nucleosides shows a preference for the purines. For iodo and propyne the 
preference was for A over G but thiazole pyrazole showed a preference for G over A 
and nitro showed a preference for A then T. It is unlikely that the results are based on 
sequence alone because the control sequence with A in the ninth position was the least 
stable. The most stable control sequence had C in the ninth position but this was the 
least stable of all of the pyrazole nucleoside strands. All four of the pyrazole nucleosides
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had a ATm range similar to that of 5-nitroindoIe (10-15 “C) but the overall change in Tm 
firom the controls was greater for the pyrazole nucleosides than for 5-nitroindole.
The results firom the incorporation into the Brown sequence show that the 
stabili^ trend seen in the Dickerson sequence is continued. In this case there was the 
possibility to incorporate only one modified nucleoside in each duplex which lessened 
the amount of destabilization. 5-Nitroindole dropped the Tm 5 degrees and the pyrazole 
nucleosides lowered it about 7 degrees. Because a single modified nucleoside can easily 
be compensated for by the duplex the difference in stability of the nucleosides is not as 
obvious. Therefore a strand was also made that incorporated three modifications.
These TmS showed more variation and surprisingly the nitropyrazole nucleoside was 
more stable than the propynepyrazole (Table 4.2).
4.7 Discussion
The stability of the pyrazole nucleosides followed the order predicted by electronic and
steric considerations. Himter et studied the importance of the issue of
electrostatics in base stacking and found that it plays a role comparable with sterics in 
establishing the sequence dependent secondary structure of DNA. Base stacking occurs 
most favorably when there is the ability to compensate for centers of negative charge on 
one base with centers of positive charge on the base with which it is stacking. A 
beautiful display of this is the helix itself which occurs because of the need to offset 
bases that are stacking to minimize negative interactions. The four natural nucleosides 
have charge distribution patterns that concentrate negative charges in different positions 
on the bases vdiich allows beneficial overlap when the bases are arranged in the 
classical double helix. Nucleosides that have little or no charge distribution may not be
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Table 4.2. Thermodynamic results of melting studies on the modified non- 
complementary strands.
Tm AH AS AG
(®C at 15 pmol ) (kcal/mol) (cal/K*moi) (kcal/mol at 2!
C o n t r o l  ( C ) 5 9 . 1 - 1 4 0 . 4 - 4 2 7 . 9 - 1 2 . 9
N 1 5 1 . 2 - 7 6 . 5 - 2 4 1 . 1 - 4 . 6
P i 6 0 . 8 - 8 8 . 2 - 2 6 9 . 4 - 7 . 9
T 1 6 0 . 6 - 1 2 1 . 7 - 3 7 0 . 1 - 1 1 . 4
D 1 5 4 . 5 - 1 2 0 . 4 - 3 7 3 . 0 - 9 . 3
N 3 3 3 . 6 - 9 1 . 6 - 3 0 4 . 0 - 1 . 0
P 3 3 0 . 1 - 9 4 . 6 - 3 1 7 . 2 - 0 . 0
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as good at accommodating the partial atomic charges of the natural nucleosides. The 
electronic charge profiles of the pyrazole bases indicate that the base with the most 
charge localization is thiazolepyrazole followed by propynepyrazole and nitopyrazole.
In addition the increasing size of the nitropyrazole, propynylpyrazole and 
thiazolepyrazole would suggest that the stability would increase in that order. Modeling 
studies (using Huckel molecular orbital calculations in Sybyl molecular modeling 
program) show that the bases stick into the major groove which allows the increasing 
size to overlap more with the base on their 5' side and increase stability. A crystal 
structure of the toluated propynepyrazole (Figure 4.8) and iodopyrazole (Figure 4.9) 
nucleosides a torsion angle of ~ 80®C for 0-CT-N1-N2. This puts the substituents on 
the edge of the major groove and allows maximum base stacking possibilities without 
introducing steric considerations. A second configuration could have been possible by 
steric interactions, the substituent sticking more directly into the major groove however 
that would have more limited stacking possibilities. While non-hydrogen bonding 
nucleosides cannot overcome the loss of energy fiom hydrogen bonds to solvent that are 
broken, the choice of a base with an ̂ propriate electronic charge distribution can 
greatly increase the stability over an abasic site or a non-polarizable substituent such as 
the phenyl ring. Kool and cowodcers^^ showed that pairing non-hydrogen bonding 
nucleoside can also increase the stability because there is no need to break hydrogen 
bonds, however, their structures were not exceptionally stable possibly in part because 
the structures are relatively unpolarizable (although diflourotoluene does have partial 
atomic charges that may be the same as T but much smaller) and may encounter some
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Figure 4.8 Crystal structure of tolulated propynepyrazole nucleoside.
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Figure 4.9 Crystal Structure of Tolulated iodopyrazole nucleoside.
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of the same problems as the phenyl ring, which is not polarizable enough to stabilize a
duplex wellJ4*17 ^  ig therefore obvious that there are many considerations when 




4-Nitropyrazole (2.769 g, 24.3 nunol) was dried and then dissolved in dry 
acetonitrile (20 mL) imder Ar. It was added dropwise to a solution of NaH (0.62 g, 25.8 
nunol) in dry acetonitrile (10 mL). at 0®C. It was stirred at room temperature imtil clear 
and then an additional 30 minutes. 3,5-Bis-O-p-toluoyl-l-chloro-P-D-ribose was added 
(11.94 g, 30.7 mmol) and the solution was stirred under Ar. for 3 hows. The solution 
was filtered and the filtrate was washed with CH3CN. The solution was concentrated 
under reduced pressure and purified by silica column (CHCI3) to yield 12.24 g (86 %) of 
a white solid. m.p. 154® C; TLC: Rr=0.50 (1:2 EtOAc-Hexanes) HRMS FAB (MNBA) 
Theoretical: 466.1614 (M+H)\ Found: 466.1606 (M+H)^. ‘H (200 MHz, CDCI3) 5 8.36 
(s, IH, H-5), 8.06 (s,lH, H-3), 7.94 (d, Jat=8.2, 2H, Ar), 7.88 (d, Jat=8.3, 2H, Ar), 7.27 
(d, Jat=8.1, 2H, Ar), 7.22 (d, Jat=8.3, 2H, Ar), 6.20 (app.t, Jh2-=6 .0, 1H, HI"), 5.77 (app. 
dt, Jh2-=32, Jh4-=6 .3, 1H, H3*), 4.70-4.63 (m, 2H, H4' & H5"), 4.54 (dd, Jh4-=6 .2 , 
Jh5-=13.5, 1H, H5"), 3.22 (app. dt, J=6.2, Jh2-=14.2, 1H, H2'), 2.85 (ddd, Jh3-=4.0 , 
Jhi-=6.4, Jh2-=14.4, IH, H2"), 2.44,2.41 (s, 3H, CHj-Ar). (50 MHz, CDCI3) 166.10, 
165.80 (C(O)-Ar), 144.48, 144.11 (C(O)-Ar), 136.22 (C5), 129.65,129.56, 129.16, 
129.06, (Ar), 127.86, (C3), 126.58, 126.33 (Ar-CHs), 105.00 (C4), 90.66 (CIO, 83.60 
(C40,74.56 (€30,63.61 (€50,37.80 (€20,21.60,21.55 (Ar-CHa).
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4.8^ l-(2'-Deoxy-P-D-ribofunuio^l)-4-iiitropyrazole (3c).
l-(2'-Deoxy-3’,5'-Bis-0-p-toluoyl-P-D-ribofuranosyl)-4-nitropyrazole (1.65 g, 
3.55 mmol) was suspended in methanol (100 mL) and then 100 mL of ammonia 
saturated methanol was added. The solution was stirred for 24 hours, and then 
concentrated under reduced pressure. It was purified by silica column (4:5 
CHzClz/EtOAc) to give a yeUowish oU (0.717g, 88%). TLC: Rf=0.17 (1:2 CH2CI2- 
EtOAc) . HRMS FAB (MNBA) Theoretical: 230.0776 (M+H)\ Found: 230.0756 
(M+H)+. ‘H NMR (200 MHz, CD3OD) 5 8.76 (s, IH, H5), 8.12 (s, IH, HI), 6.14 (app. 
t, Jh2-=6 .4, IH, HIO, 4.50 (app. dd, Jh2*=5.5, Jh4-=10.5, IH, H3"), 4.02 (app. dd, Jh5̂ - 3, 
Jh3-=8.7, IH, H4’), 3.75 (dd, Jh4-=3.7, Jhs^I 1.9, IH, H5"), 3.64 (dd, Jh4-=5.17, Jh5-=12.0, 
IH, H5'), 2.84-2.71 (m, IH, H2*), 2.52 (ddd, Jh3-=L7, Jhi-=7.1, Jh2-=13.9, IH, H2).
(250 NMR, CD3OD) Ô 137.01 (C5), 130.01 (C3), 92.15 (Cl*), 89.70 (C4’), 72.17 (C3'), 
63.35 (C53,41.44 (C2").
4.83 l-(2'-Deoxy-5’-dimethoxytrityl-P-D-ribofuraiiosyl)-4-nitropyrazole (4c).
l-(2'-Deoxy-P-D-ribofuranosyl)-4-nitropyrazole (0.717g, 3.13 mmol) was co­
evaporated with pyridine three times (1 mL) and then dissolved in dry pyridine(15 mL) 
and DIEA (10 mL) under Ar. DMT-Cl (1.08 g, 3.18 mmol) and DMAP (0.38 g, 3.11 
mmol) were dried and added to the solution. It was stirred for 24 hours. Water (250 
mL) was added and the product extracted with ether (3 x 100 mL). The combined ether 
layers were washed with NaHCOs, and brine then dried with Na2S04 and concentrated 
under reduced pressure. It was purified by alumina column (20:1 EtOAc-CHgOH) to 
give 1.47 g (88%) of oU. TLC: Rf = 0.18 (4:3:1 Hexanes-EtOAc-EtsN) FAB MS (NBA)
531.4 (M+H)+ IH (250 MHz, CDCI3) 6 8.33 (s, IH, H5), 8.01 (s, IH, H3), 7.38 (app. d.
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J=7.6,2H, Ar), 7.30-7.14 (m, 7H, Ar), 6.80 (app. d, J=8.7,4H, Ar), 6.04 ( app. t, 
Jm-5.7, IH, HI"), 4.57 (app. dd, J=5.6, J=10.5, IH, H3"), 4.19 (app. dd, J=4.4, J=8.8, 
IH, H4"), 3.74 (s, 6H, OMe), 3.30-3.22 (m, 2H, H5’ & H5"), 2.79-2.69 (m, IH, HZ'), 
2.57-2.43 (m, IH, H2"). ‘̂ C (300 MHz, C D 3 O D )  Ô  160.12 (Ar-OMe), 146.38 (C5),
137.25,137.17 (Ar-C), 136.96 (C3), 131.35, 129.99, 129.38, 128.83, 127.87 (Ar),




l-(2'-Deoxy-5*-dimethoxytrityI-p-D-ribofviranosyl)-4-mtropyrazole (0.52g, 0.98 
mmol) was twice co-evaporated with pyridine. It was then dissolved in CH2CI2 (5 mL) 
and triethylamine (0.75 mL) under Ar. The diisopropylchlorocyanoethyl 
phosphoramidite (0.3 mL, 1.3 mmol) was added slowly and it was stirred for 15 
minutes. It was quenched with methanol and then washed with brine. It was dried with 
Na2S04 and concentrated under reduced pressure. It was purified by alumina column 
(2:1 Hexanes/EtOAc) to give a white foam (0.6224g, 87%). TLC: Rf = 0.70 (4:3:1 
Hexanes-EtOAc-EtsN). HRMS FAB Theoretical: 732.3161 (M+H)^. Found: 732.3153 
(M+H) .̂ ‘̂P mixture o f diasteromers (101.2 MHz, CDCI3) 5 147.81, 147.63. *H 
mixture of diasteromers (250 MHz, CDCI3) S 8.37, 8.35 (s, IH, H5), 8.04 (s, IH, H3), 
7.39-7.36 (m, 2H, Ar), 7.29-7.20 (m, 7H, Ar), 6.82-6.78 (m, 4H, Ar), 6.08 (dd, Jh2-=5.8, 
Jh2-=8.7, IH, HI"), 4.68 (m, IH, H4"), 4.28 (app. t, J=4.2, IH, H3"), 3.78 (s, 6H, OMe), 
3.70-3.52 (m, 4H, CH3-CH and O-CH2), 3.26 (dd, J=7.4, J=14.3,2H, H5’and H5"), 
2.84-2.56 (m, 4H, C2 and CH2-CN), 1.26-1.08 (m, 12H, CH3-CH).
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4.8^ l-(2'-Deoxy-3'^'-Bis-0-p-tolaoyl-p-D-ribofiiranosyI)-4-iodopynizole (2a).
4-Iodopyrazole (6.481 g, 33.4 mmol) was dried and then dissolved in dry 
acetonitrile (30 mL) under Ar. It was added dropwise to a solution of NaH (1.01 g,
42.09 mmol) in dry acetonitrile (20 mL). at 0®C. It was stirred at room temperature until 
clear and then an additional 30 minutes. 3, 5-Bis-O-p-toluoyl-l -chloro-P-D-ribose was 
added (13.01 g, 33.7 mmol) and the solution was stirred under Ar. for 3 hours. The 
solution was filtered and the filtrate was washed with CH3CN. The solution was 
concentrated under reduced pressure and purified by silica column (3:2 CH2CI2- 
Hecanes) to yield 13.26 g (72 %) of a white solid. m.p. 110 °C. TLC: Rf= 0.66 (1:2 
EtOAc-Hexanes). FABMS (Glycerol) 547.3 (M+H) ;̂ ‘H (250 MHz, CDCI3), 7.94 (d, 
J a t = 4 . 1 ,  1 H ,  Ar), 7.91 (d, J a t = 4 . 2 ,  IH, Ar), 7.64 (s, IH, H5), 7.54 (s, IH, H3), 7.27 (d, 
J a t = 2 . 9 ,  IH, Ar), 7.22 (d, J a t = 7 . 8 ,  IH, Ar), 620 (t, Jh2=6.2, IH, HI*), 5.75 (dd, J=2.8, 
J=5.9, IH, H3’), 4.63-4.49 (m, 3H, H4 and H5), 3.20-3.09 (m, IH, H2'), 2.66 (ddd,
J=3.7,6.2,9.8, IH, H2"), 2.42 (s, 3H, CH3), 2.41 (s, 3H, CH3). (75 MHz, CDCI3) S,
166.17 (C(0)), 165.82 (C(0)), 145.23 (C5), 144.26 (C(O)-Ar), 143.82 (C(O)-Ar),
133.19 (C3), 129.66 (Ar), 129.11 (Ar), 126.83 (Ar-CH3), 126.55 (Ar-CH3), 89.84 (Cl*),
82.84 (C4"), 75.06 (C3*), 64.03 (C5"), 37.41 (C20,21.66 (CH3). Anal. Calcd for 
C24H23IN2O5: C 52.76, H 4.24, N 5.13. Found: C 52.57, H 4.50, N 5.11.
4.8.6 l-(2'-Deoxy-p-D-ribolaranosyl>-4-iodopyrazole (3a).
l-(2'-Deoxy-3',5'-Bis-G-p-toluoyl-P-D-ribofuranosyI)-4-iodopyrazoIe (2.08 g,
3.8 mmol) was suspended in methanol (100 mL) and then 100 mL of ammonia saturated 
methanol was added. The solution was stirred for 24 hours, and then concentrated 
under reduced pressure. It was purified by silica colunm (4:5 CHzClz/EtOAc) to give a
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yeUowish oü (1.013 g, 86%). TLC: Rf=0.39 (9:1 CHCI3-CH3OH). FABMS (Glycerol)
311.3 (M+H)"̂ . ‘H (250 MHz, CDCI3) ô 7.60 (s, IH, H5), 7.59 (s, IH, H3), 6.11 (t, 
J h 2 = 6 . 4 ,  IH, Hl*), 4.74 (dd, J=2.7,5.6, IH, H3"), 4.13 (app. d, J=2.4, IH, H4’), 3.88 (dd, 
J h 4 - = 2 . 0 ,  J h 5 - = 1 2 . 6 ,  IH, H5*), 3.72 (dd, Jm-=2.0, J h 5 ^ 1 2 . 6 ,  1 H ,  H5"), 2.89-2.78 (m, IH, 
H2’), 2.41 (ddd, J=3.1, J=6.8, J=13.8, IH, H2'). "C (62.5 MHz, CDCI3) 5 145.78 (C5),
134.11 (C3), 89.92 (Cl*), 89.04 (C4*), 72.72 (C3"), 63.36 (C5"), 41.64 (C2"). Anal. Calcd 
for C»H,|N203: C 30.99, H 3.58, N 9.03. Found: C 30.75, H 3.80, N 9.05.
4.8.7 l-(2'-Deoxy-5'-dimethoxytrityl-P-0-ribofnranosyi)*4-iodopyrazole (4a).
1 -(2-Deoxy-P-D-ribofuranosyl)-4-iodopyrazole (0.9991g, 3.23 mmol) was co- 
evaporated with pyridine three times (1 mL) and then dissolved in 10 mL of dry 
pyridine and 8 mL of DIE A under Ar. DMT-Cl (1.05 g, 3.09 mmol) and DMAP 
(0.4245 g, 3.47 mmol) were dried and added to the solution. It was stirred for 24 hours. 
250 mL of water was added and the product extracted with ether (3 x 100 mL). The 
combined ether layers were washed with NaHCOg, and brine then dried with NaiSO# 
and concentrated under reduced pressure. It was purified by alumina column (4:3:1 
Hexanes-EtOAc-Et3N) to give 1.45 g (73%) of oil. m.p. = 35®C. TLC: Rf==0.34 (4:3:1 
Hexanes-EtOAc-Et3N). FABMS (NBA) 612.6 (M+H) .̂ ‘H (200 MHz, CDC13) 5 7.64 
(s, IH, H5), 7.46 (s, IH, H3), 7.40 (app. d, J=8.0,2H, Ar), 7.24-7.16 (m, 7H, Ar), 6.80 
(app. d, J=8.2,4H, Ar), 6.09 ( app. t, Jh2-=5.1, IH, HI"), 4.62-4.57 (m, IH, H3"), 4.19 
(app. dd, J=4.2, J=8.8, IH, H4'), 3.78 (s, 6H, OMe), 3.34-3.17 (m, 2H, H5' & H5"), 
2.79-2.67 (m, IH, H2"), 2.57-2.438 (m, IH, H2"). Anal. Calcd for C29H29IN2OS: C 
56.87, H 4.77, N 4.57. Found: C 56.71, H 4.89, N 4.61.




l-(2'-Deoxy-5'-<Iimethoxytrityl-P-D-ribofuranosyI)-4-iodopyrazole (0.39g, 0.64 
mmol) was twice co-evapoiated with pyridine. It was then dissolved in CH2CI2 (5 mL) 
and triethylamine (0.4 mL) under Ar. The diisopropyichlorocyanoethylphosphoramidite 
(0.15 mL, 1.05 mmol) was added slowly and it was stirred for 1 hour. It was quenched 
with water and then washed with brine. It was dried with Na2S04 and concentrated 
under reduced pressure. It was purified by alumina column (2:1 Hexanes/EtOAc) to 
give a white foam (0.366 g, 71 %). TLC: Rf=0.35 (4:3:1 Hexanes-EtOAc-EtsN). HRMS 
FAB (MNBA) Theoretical: 812.2159 (M). Found: 813.2262 (M+H)^ (101.2
MHz, CDCI3) mixture of diasteromers Ô 147.62,147.35. 'H mixture of diasteromers 
(250 MHz, CDCI3) 8 8.23 (s, IH, H5), 7.68 (s, IH, H3), 7.42-7.39 (m, 2H, Ar), 7.31-
7.19 (m, 7H, Ar), 6.82-6.78 (m, 4H, Ar), 6.05 (app. t ,  J h2-= 5 .9 , IH, HI"), 4.69-4.63 (m, 
IH, H4*), 4.20-4.16 (m, IH, H3'), 3.78 (s, 6H, OMe), 3.66-3.48 (m, 4H, CH3-CH and O- 
CHz), 3.24-3.21 (m, 2H, H5"), 2.78-2.40 (m, 4H, C2 and CH2-CN), 199 (s, 3H, 
CH3),1.32-1.12(m, 12H, CH3-CH).
4.8.9 1 -(2'-Deoxy-3',5'-Bis-0-/^toluoyl-P-D-ribofurano^l)-4-propyny Ipy razole 
(2d).
l-(2'-Deoxy-3',5'-Bis-0-^toluoyl-P-D-ribofuranosyl)-4-iodopyrazole (7.1 g, 13 
mmol) was introduced into a 280 mL pressure reactor. DMF (70 mL) and triethylamine 
(15 mL, 107.6 mmol) were added and the solution was purged with Ar and sonicated (3 
times). The flask was cooled to -78°C and 14 mL of propyne (247.17 mmol) was 
condensed. Copper iodide (0.5011 g, 2.63 mmol) and Fd(GAc)2(Fh3P-resin) (0.801 
mmol) w ae added and the flask was sealed and warmed to room temperature. It was
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stirred for 24 hours. The solvents were removed under reduced pressure and the product 
was purified by silica column (DCM) to give 5.75 g of a white solid (96 %). m.p. TLC: 
Rf=0.22 (3:1 Ether-Hexanes). FABMS (glycerol) 459.1 (M+H)^. ‘H (250 MHz,
CDCh) Ô 7.93 (d, J/vr=7.9,4H, Ar), 7.65 (s, IH, H5), 7.57 (s, IH, H3), 7.27 (d, J a t = 2 . 4 ,  
2H, Ar), 7.21 (d, J a t = 7 . 7 ,  2H, Ar), 6.16 (t, J h 2 - = 6 . 1 ,  IH, HI*), 5.76 (app. dd, J h 2 - = 3 . 2 ,  
J h 4 - = 6 . 4 ,  IH, H3'), 4.60-4.48 (m, 3H, H4' and H5’), 3.21-3.11 (m, IH, H2), 2.66 (ddd, 
J h i = 6 . 6 ,  J h 3 = 3 . 7 ,  J h 2 = 1 4 . 4 ,  IH, H2’), 2.42 (s, 3H, Ar-CHj), 2.40 (s, 3H, Ar-CHj), 1.99 
(s, 3H, C-CH3). ‘̂ C (50 MHz, CDCI3) Ô 166.25 (C(0)), 165.87 (C(0)), 144.26 (C(0)- 
Ar), 143.78 (C(O)-Ar), 142.75 (C5), 131.10 (C3), 129.78 (Ar), 129.22 (Ar), 129.12 
(Ar), 129.02 (Ar), 126.98 (Ar-CHs), 126.67 (Ar-CHs), 104.83 (C4), 89.78 (Cl*), 86.52 
(Pyrazole-C), 82.74 (C4% 75.21 (C3'), 70.24 (C-CH3), 64.21 (C5"), 37.35 (C7), 21.69 
(Ar-CHa), 4.27 (C-CH3). Anal. Calc’d for C27H26N2O5: C70.73, H 5.72, N 6.11. Found: 
C 70.56, H 5.71, N 5.92
4.8.10 l-(2'-Deoxy-p-D-ribofaranosyI)-4-propynylpyrazole (3d).
l-(2'-Deoxy-3’,5’-Bis-0-p-toluoyl-P-D-ribofi]ranosyl)-4-propynylpyrazoIe (1.0 g, 
2.18 mmol) was suspended in methanol (100 mL) and then K 2 C O 3  (5.1g) was added.
The solution was stirred for 18 hours, and then the potassium carbonate was filtered and 
the solvent removed under reduced pressure. It was purified by silica column (1:2 
CH2Cl2/EtOAc) to give a yellowish oU.(0.41 g, 85%). TLC: Rf=0.24 (9:1 CHCI3- 
CH3OH). 'H (250 MHz, CDCI3) 8 7.60 (s, IH, H5), 7.56 (s, IH, H3), 6.00 (t, Jh2=6.2, 
IH, HI"), 5.09 (app. d, J=5.4, IH, H3*), 4.04 (app. d, J=2.3, IH, H4% 3.81-3.77 (m, IH, 
H5"), 3.69-3.61 (m, IH, H5"), 2.74-2.63 (m, IH, HZ'), 2.32 (ddd, J=1.5, J=5.8, J=13.0,
IH, HZ'), 1.96 (s, 3H, CH3). ‘̂ C (62.5 MHz, CDCI3) 5 143.00 (C5), 131.68 (C3),
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104.04 (C4), 89.79 (Cl% 88.87 (C4% 86.69 (pyrazoIe-C), 72.44 (C3*), 69.76 (C-CHj), 
63.25 (C5"), 41.50 (C2% 4.15 (C-CH3).
4.8.11 l-(2'-Deoxy-5'-dimethoxytrityl-P-D-ribofaranosyI)-4-propynylpynizole (4d).
l-(2'-Deoxy-P-D-ribofuranosyl)-4-propynyIpyrazole (0.41 g, 1.8 mmol) was co­
evaporated with pyridine three times (5 mL) and then dissolved in 15 mL of dry 
pyridine and 6 mL of DEEA under Ar. DMT-Cl (.9387 g, 2.77 mmol) and DMAP 
(0.3378 g, 2.76 mmol) were dried and added to the solution. It was stirred for 48 hours. 
250 mL of water was added and the product extracted with ether (3 x 100 mL). The 
combined ether layers were washed with NaHCOs, and brine then dried with NazSO# 
and concentrated under reduced pressure. It was purified by alumina column (4:3:1 
Hexanes-EtOAc-EtsN) to give 0.7568 g (83%) of oil. TLC: Rf=0.54 (4:3:1 Hexanes- 
EtOAc-EtaN). ‘H (200 MHz, CDCI3) S 7.54 (s, IH, H5), 7.41 (s, IH, H3), 7.34-7.31 
(m, 2H, DMT), 7.23-7.07 (m, 7H, DMT), 6.75-6.69 (m, 4H, DMT), 5.93 (dd, J h2-=4.6, 
J h2-=6.6, IH, HI"), 4.50 (dd, J=5.8, J=10.9, IH, H3'), 3.92 (dd, J=5.1, J=10.I, IH, H40, 
3.71 (s, 6H, OCH3), 3.27-3.09 (m, 2H, H5"), 2.73-2.61 (m, 2H, H2*), 1.91 (s, 3H, CH3). 
'̂ C (50 MHz, CDCI3) 6 158.48 (Ar-OCH3), 149.10,144.67 (DMT), 142.24 (C5),
135.84 (C3), 130.73, 130.02, 128.13, 127.82, 126.76,113.14 (DMT), 104.39 (C4),
8924 (Cl'), 86.40 (C-(Ar)3), 85.63 (Pyrazole-C), 85.63 (C4"), 72.37 (C3'), 70.42 (C- 




g, 222 mmol) was twice co-evaporated with pyridine. It was then dissolved in CH2CI2
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(5 mL) and triethylamine (1.5 mL) under Ar. The diisopropyichlorocyanoethyl 
phosphoramidite (0.3 mL, 1.34 mmol) was added slowly and it was stirred for 1 hour. It 
was quenched with methanol and then washed with brine. It was dried with NazS04 and 
concentrated under reduced pressure. It was purified by alumina column (2:1 
Hexanes/EtOAc) to give a white foam (1.315 g, 89 %). TLC: Rf= 0.56 (4:3:1 Hexanes- 
EtOAc-EtsN). HRMS FAB (MNBA) Theoretical: 724.3389 (M). Found: 725.3427 
(M+H)^ (101.2 MHz, CDCI3) mixture of diasteromers ô 155.28,155.01. 'H
nuxture of diasteromers (250 MHz, CDCI3) 8 7.67 (s, IH, H5), 7.50 (s, IH, H3), 7.43- 
7.40 (m, 2H, Ar), 7.31-7.19 (m, 7H, Ar), 6.82-6.78 (m, 4H, Ar), 6.05 (app. t, Jh2-=5.9, 
IH, HI*), 4.69-4.63 (m, IH, H4*), 4.20-4.16 (m, IH, H3"), 3.78 (s, 6H, OMe), 3.66-3.48 
(m, 4H, CH3-CH and O-CH2), 3.24-3.21 (m, 2H, H5"), 2.78-2.40 (m, 4H, C2 and CHz- 
CN), 1.99 (s, 3H, CH3),1.32-1.12 (m, 12H, CH3-CH).
4.8.13 Synthesis and Characterization of OUgodeoxyribonucIeotides.
OUgodeoxyribonucleotides were prepared from commercially available dA, dC, 
d o ,  dT (Applied Biosystems division of Peridn Elmer) and d(5-nitroindole) (Glen 
Research) on an ABI synthesizer using standard solid phase phosphorantidite chemistry 
(l|iM  scale). Stepwise coupling yields ranged from 80 to 100 %. The 5'-trityl protected 
oligonucleotides were removed firom the CPG and deprotected by treatment with 
concentrated NH3 at 55°C for 8 hours. The oligonucleotides were purified using 
Oligopurification Cartridges from ABD-Perkin-Elmer according to the manufacture's 
instructions. The purified oligomers were evaporated to dryness using a centrifuge 
ev^wrator and stored at -5®C. The purity was detemtined by reverse-phase HPLC 
(Waters 486 equipt with a Supelco LC-18S SUPELCOSIL C18 (4.9x250 mm) column
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using 95% IM triethylammonium acetate (TEAA) and 5% .05M (TEAA) 4:1 CH3CN- 
H2O initial conditions going to 75% IM triethylammoniinn acetate (TEAA) and 25% 
.05M (TEAA) 4:1 CH3CN-H2O) and they were characterized by MALDI mass 
spectrometry.
4.8.14 Thermal Dénaturation Studies
Solvent Preparation. An estimate o f the amount of oligonucleotide needed was 
determined by UV(260 nm) (Gilford) in H2O and then the sample was evaporated to 
dryness using a centrifuge evaporator. The samples were dissolved in a pH 7 buffer of 
4x(1.0 M NaCU 10 mM sodium phosphate, and 0.1 mM EDTA) and diluted fourfold. 
Where necessary serial dilutions were made. All solvents were degassed in a vacuum 
desiccator prior to use. The concentration was determined using the assumption that at 
high temperature the oligonucleotides are unstacked and unpaired. The absorbance was 
determined at 80°C and Beer's Law (A=ecl) was used to determine the concentration 
utilizing an estimate of the extinction coefficients as calculated below.
Calculation o f extinction coefficient estimates. The extinction coefficient 
(5.818,0.101,0.127) of each of the unprotected modified nucleosides (nitro, iodo, 
propynyl and thiazoyl) was determined by making a Beer’s Law plot of the absorbance 
(260 nm) at each of 5 known concentrations. The extinction coefficient of 5-nitroindole 
was supplied from Donald Bergstrom (15.296). The absorbance of the intact 
oligonucleotide was measured (260 nm in a Tris sodium phosphate buffer) and then the 
oligonucleotide was digested with snake venom phosphodiesterase. The absorbance 
was read for the solution that then contained the completely unbound nucleosides. A 
ratio was developed between the two to account for the hypochromicity. The summation
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of the mononucleotides are made and then multiplied by the hypochromicity factor to 
determine the extinction coefBcients. For the self-complemantary strands, the nearest 
neighbor estimate of each of the four control sequences was determined using the 
method and values from Gratzer and Richards.^^ The sum of the extinction o f the 
mononucleotides was also determined and a ratio of nearest neighbor to sum of
mononucleotides was made.^^ The sum of the individual mononucleotides 
(incorporating the calculated extinction coefficients of the modified nucleotides) was 
calculated for the modified strands and these were multiplied by the ratio to account for 
nearest neighbor effects.
UV melting measurements. Absorbance versus temperature profiles were determined at 
260 nm on a Gilford spectrometer equipped with a Peltier temperature controlling 
device and thermal software. The average of 3-5 absorbance readings was determined 
at 5®C and/or 25®C before and after each melt to determine that evaporation was less 
than 5%. Nitrogen was run through measurement chamber to prevent condensation. 
Prior to measurement all samples were heated to 95®C for 2 min to drive the equilibrium 
to duplex. They were then cooled to 5®C and equilibrated for 5 minutes. One 
concentration for each duplex was determined in both a heating and cooling ramp to 
ensure that the duplex behaved the same way. Then 4-5 concentrations (covering 100- 
fold concentration difference) were run in a heating run at I°C/min utilizing pathlenghts 
of 0.01 cm to 1 cm. For each of the concentrations a curve was generated that related 
absorbance to temperature called a melting curve. Equation 4.1 was developed by
Gralla and Crothers^^ for the analysis of melting curves. It corresponds to the 
derivative of the melting curves.
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Table 4.4 Extinction coefBcients






Nitro A 0.892 112.50
Nitro C 0.894 105.59
Nitro G 0.886 108.28
Nitro T 0.872 104.13
lodo A 0.892 107.40
lodo C 0.894 100.49
lodo G 0.886 103.22
lodo T 0.872 99.15
PropyneA 0.892 107.42
Propyne C 0.894 100.50
Propyne G 0.886 103.24
Propyne T 0.872 99.16
Complementary Strand 0.868 147.5
Control Strand 0.819 162.3
Nitro 1 0.807 158.6
Nitro 3 0.804 153.4
Propyne 1 0.737 140.6
Propyne 3 0.682 118.6
Indole 1 0.770 158.7
Indole 3 0.734 160.97
Thiazole 1 0.834 164.8
Thiazole 3 0.808 156.9
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ôa
L ^ i /n J
a(l -  à)/SH 
(\-^a)R
Equation 4.1. Equation for the derivative of a melting curve.





Figure 4.10 Graph of the derivative with values of alpha of 0—>̂ 1.
At the maximum of the derivative curve a=0.414 as shown by the graph o f the 
derivative using values of alpha corresponding to 0—>1 (Figure 4.10). In addition the 
second derivative of the melting curve is equal to zero at the inflection point (Tmax of
âa 0 .1 7 2 A J ^  
R
Equation 4.2. Derivative of melting curve at T»., (o=0.414)
the derivative curve) of the melting curve (this also defines cc=0.414 at Tmax). If you 
plug the value a=0.414 back into Equation 4.1 then you get Equation 4.2. However the
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melting temperatuieCTm) is defined as the temperature when there is an equal number of 
strand that are in a duplex as there are single stranded or when oc=0.5. When a=0.5 is 
plugged into Equation 4.1, Equation 4.3 results. Therefore to calculate Tm (o=0.5)
da 0.167 A// 
R
Equation 4 3 .  Derivative curve when ce= 0 3 .
from Tmax (o=0.414) Equation 4.4 is used. However Equation 4.4 can be simplified to
da _  0.167 da
U i / r . ) J 0.172 _^1/T_x)_
Equation 4.4. Ratio to calculate Tm from Tmax
multiplying Tmax by 0.971 to obtain Tm- A plot o f l /T m  (in Kelvin) versus In(C) was 
made using the 4-5 concentrations as shown in Figure 4.11. From the slope and
Graph ofl/Tm versus Ln(C)
0.003










Figure 4.11 Graph of 1/Tm versus Ln(C) using various concentrations.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
94








Control GC 2.1 3.07 8 0.995
Control AT 2.4 3.13 5 0.997
Control TA 2.6 3.19 4 0.995
Control CG 2.7 3.13 4 0.998
5-nitroindole-A 8.1 3.55 3 0.851
5-nitroindole-C 4.9 3.41 3 0.994
5-nitroindole-G 5.8 3.48 3 0.999
5-nitroindole-T 4.0 3.35 3 0.999
Nitro A 4.0 3.51 4 0.986
Nitro C 5.3 3.66 6 0.988
Nitro G 6.0 3.69 4 0.989
Nitro T 5.3 3.62 4 0.996
lodo A 7.0 3.71 6 0.991
lodo C 5.9 3.78 5 0.998
lodo G 6.7 3.75 5 0.999
lodoT 6.3 3.76 4 0.935
Propyne A 4.8 3.52 7 0.973
PropyneC 6.8 3.78 5 0.988
Propyne G 3.7 3.53 4 0.990
Propyne T 9.4 3.79 4 0.999
Control Strand 1.4 3.05 3 0.989
Nitro 1 2.6 3.15 3 0.989
Nitro 3 2.2 3.32 3 0.993
Propyne 1 2.3 3.06 3 0.76
Propyne3 2.1 3.35 2 1.00
Indole 1 1.6 3.10 2 1.00
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intercept of the line the thermocfynamics could be determined. The values of the slope, 
intercept and fît are given in Table 4.5. The thermodynamic parameters were calculated
using equations 4.5-4.7.38
A H = -^  
Slope
Equation 4.5. Equation used to calculate AH.
AS = A /f X intercept
Equation 4.6. Equation used to calculate AS.
AG = AH-TxAS
Equation 4.7. Equation used to calculate AG.
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Chapter 5 
Pofymerase Chain Reaction
The polymerase chain reaction (PCR) is a process used to amplify DNA. It 
utilizes a pair of synthetic primers flanking the region of a template that needs to be 
amplified (with their 3’ends facing each other) where each is complementary to a 
different DNA strand and an enzyme that extends the primer oligonucleotide according
to the template to which it is complementary J  Initially the Klenow fragment of E.coli 
was used as the extension en^rme, however the dénaturation step (which is required to 
separate the complementary template strands) inactivated the enzyme which proved to 
be costly and tedious. Therefore the reaction did not enjoy a great deal of success until 
the discovery of the Thermus aquaticus (Taq polymerase) enzyme in the geysers of
Yellowstone National Park.2 This enzyme was useful under a much greater range of 
temperature conditions than prior enzymes which allowed the reaction to work more
reliably and with greater specificity for a wide range of compounds.^ In addition the 
Taq polymerase does not contain a 3-5' proofreading exonuclease activity which means 
the enzyme can not remove the trailing nucleotides in an attempt to "correct" the
sequence.̂  This prevents the nucleosides from being removed once they were inserted 
but also meant there was no mechanism for correction if a nucleoside was inserted 
incorrectly (meaning it was not the natural complement to that space on the template). 
This allows the process to create some mistakes or mismatches at a rate which can be 
cause for concern. Additionally the process suffers from cross-contamination (a
98
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consequence of its extreme sensitivity) and the limitation on the size that can be 
amplified (above about 1 kb the efficiency declines). However these problems are being
addressed.^
5.1 Applications of PCR
PCR has been used for a variety of applications. The most obvious is for the 
production of large amounts o f oligonucleotides. In addition it as been used in the 
determination of the preference of nucleotides for the natural nucleotides and to 
determine the relative stability of modified nucleotides. It could also be used to detect 
point mutations in DNA.
5.1.1 Amplification of DNA
The amplification of DNA is the most straightforward application of the 
polymerase chain reaction. It has been applied to the analysis of DNA fix>m mummies, 
forensic purposes, amplification of viruses in experimental medicine, diagnosis of 
genetic diseases and a variety of other applications.^ In this reaction the DNA that 
needs to be amplified is called the template. Both strands of a double stranded helix are 
generally amplified although this is not necessary. However if only one strand is 
amplified the rate of amplification is much slower, increasing only by the amount of the 
template each round. If both strands are amplified the rate of amplification is 
exponential and can result in the amplification of DNA by a million times or more in 
25-45 cycles. In addition to the template there must be a supply of primers for any 
sequence that is going to be amplified. The primer must be complementary to the 
section of the template corresponding to the beginning of the desired oligonucleotide at 
the 5' end. Therefore if only one strand of the double stranded helix is going to be
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amplified the template must be the complement to the desired product. The reaction 
also uses a supply o f ATP-nucleosides.
The components are introduced to the reaction and it is initially heated to 
^xproximately 95°C for about a minute to denature the double helix. The reaction 
mixture is then cooled to 35**C to allow the primers and templates to anneal. This is 
promoted by the use of a large excess of primer (usually 100 fold or more depending on 
the amount of amplification needed). The extension reaction is effected at a 
temperature of 50-55®C for several minutes. This allows the enzyme to coordinate with 
the primer-template duplex and to extend the oligonucleotide with the ATP nucleosides. 
The reaction mixture is then denatured and the daughter strands are used as templates as 
well as the original templates. Therefore the product increases exponentially. A 
diagram of this process is shown in Figure 5.1.
5.1.2 Determination of Preference for Natural Nucleotides
PCR can be used as a tool to aid in the determination of the preference for the 
natural nucleotides by modified nucleotides. It can provide added depth to the 
information provided by thermal melting studies. In general the modified nucleosides
are incorporated into an oligonucleotide and subjected to a PCR reaction.7,8,9 in 
addition the modified nucleotides can be converted to ATP nucleosides and used as the 
building blocks in the extension of a normal primer. When the modified nucleoside is 
in the primer the goal is to determine the ratios of the four normal nucleosides that are 
incorporated into the primer strand versus the modified spot in the template This gives 
the preferred nucleoside that is "written" against a modified nucleoside. When the
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nucleoside is converted to an ATP nucleoside and used in PCR the goal is to determine 
the nucleoside that the modified nucleoside prefers to "read".
The reaction utilizing modified nucleosides follows the same procedure as in a 
normal PCR reaction but incorporates the modified nucleosides into the primer or 
nucleoside supply. However the reaction conditions may have to be modified slightly to 
account for the difference in the stability of the duplex and the ability of the enzyme to 
complex the modified duplex. Potentially the PCR reaction may not proceed at all in 
the presence of a modification either because the duplex is not stable enough or because 
the ability of the enzyme to bind to the duplex has been severely hampered.
5.13 Determination of Relative Stability of Nucleosides
This approach has recently been used by Kool and co-workers^® based on the 
prior work of Goodman and co-workers. ̂  ̂  Strictly speaking these reactions generally 
are not chain reactions in that they do not occur in repetitive loops that greatly amplify 
the product. They are generally conducted in one loop and the rate of incorporation of a 
single extension to the primer is. In this process the modified nucleotide is incorporated 
into the template of interest and the rate of extension was observed. This can be used to 
make comparisons on the stability of various modified nucleosides. The incorporation 
of each of the four nucleosides is incorporated individually against the modified 
nucleoside and the rate is measured. The fastest rate corresponds to the most stable pair. 
However it should be cautioned that the rate of extension is dependent not only on the 
stability of the duplex (which is a direct result of the stability imparted by the 
nucleoside) but also on the likelihood of the entyme to bind to the duplex and allow
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extension. In order to get an accurate rate based on the modified nucleoside only, the 
binding constant must be taken into account.
5.1.4 Use of PCR to Detect Point Mutation
PCR in conjunction with modified nucleoside can be used to detect point 
mutations in DNA. This is accomplished by "converting" a nucleoside in the normal 
strand into a restriction endonuclease site. The point mutation does not get converted in 
the process. This process takes advantage of the fact that some modified nucleoside 
prefer to "read" and "write" different natural nucleosides. With a group of nucleosides 
designed to cover each possible desired conversion (16 possibilities) the conversion 
could just mean the appropriate choice of modified nucleoside. Both strands get 
amplified and then when subjected to a restriction endonuclease the normal strands are 
eliminated and the "mutant" strands can be detected. In this process it must be noted 
that PCR does create mutations at a rate of 1 in 10^-10^12,13 which could effect results 
if not accounted for or corrected.
SJL Target of the PCR Experiments
The results we hope to obtain fix>m PCR was to determine if the modified 
nucleosides can function in a PCR reaction and to assess their potential as "convertides" 
or nucleosides that effect the change of a single nucleotide in DNA to aid in the 
detection of point mutations. Therefore the series of pyrazole nucleoside 1 -(4- 
iodopyrazole)-2-deoxy-P-D-ribosenucleoside (Figure 5.2, A), 1 -(4-nitropyrazole)-2- 
deoxy-p-D-ribosenucleoside (Figure 5.2, B), 1 -(4-propynepyrazole)-2-deoxy-P-D- 
ribosenucleoside (Figure 5.2, C), l-(4-(2-thiazoyly)pyrazole)-2-deoxy-p-D- 
ribosenucleoside (Figure 52, D) (and 5-nitronindoIe as a control) were incorporated
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Figure 5.2 Modified nucleosides used in PCR studies
into a primer 40-mer oligonucleotide. The basic procedure for the Polymerase chain
reaction was provided by Dr. Geoff Hoops. The sense strand 40-mer primer was 
designed to correspond to the positions -10 to 30 of the E. coli hisF gene in the 
expression vector phisF-tac (Figure 5.3). The antisense primer was a 30-mer that 
corresponded to positions 757 to +10 as shown in Figure 5.3. The Ms F gene is shown 
in capital letters. The sense strand is shown on the top and the antisense strand on the 
bottom. The sequence o f the template that was used for the primers is underlined. The 
position of the variable base in the sense strand is indicated by a trailing asterisk. The 
natural base is an G. Thus in the first round the primer and the antisense primers attach 
to their respective templates creating new strands that were shortened on the end closest 
to where th^r attached. The next round could have the primer and antisense primer 
attach to the original template or the slightly shortened sequences. If they attach to the 
original template then they would again create sequences slightly shortened on one end.
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Figure 5.3 Sequence of the target PCR product, the A6F gene.
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If the primer or antisense primer attach to the newly made shortened sequence then the 
extension reaction will create a strand shortened on each end, which is the target of the 
PCR reaction. This procedure was demonstrated in Figure 5.1. This group is the 
dominant product of the PCR because of the nature of the exponential increase. The PCR 
therefore created an 797 mer complementary to the hisF gene region of the template even 
though the template was much longer.
53 Procedure
The antisense primer and the primer A^ch contained the modified nucleoside 
were synthesized according to procedures outlined in Chapter 4. They were added to the 
template {phisF-tac plasmid cleaved with a restriction enzyme), the en^me (Amplitaq 
fiom Perkin-Elmer) and all four of the natural dNTPs. The product was then obtained by 
PCR as described above. There are two groups that do not accurately show the 
nucleoside that is incorporated versus the modified nucleoside and they must be removed 
prior to analysis of the sample. These are the original template strands and the sequences 
that were created slightly shortened on one end. This is accomplished by purification 
with electrophoresis using an agarose/urea gel. By comparison with “ladders” of known 
length the band for the target product can be identified and excised. The product is then 
extracted fix>m the gel using a crush and soak technique. The purified target nucleoside is 
then sequenced to determine which base (or the percentages o f each base if more than one 
is incorporated) is incorporated. This is accomplished by setting up four reactions where 
each one uses a different dideoxynucleotide. The target oligonucleotide and a primer for 
the strand of interest is put into each of the four reactions along with the necessary 
enzyme. After the reaction is complete the strands are purified by electrophoresis
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Figure 5.4 Agarose gel separation of the target oligonucleotide after PCR.
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usû% an aciylamide gel and the sequence can be determined. In this example the strand 
we sequence is the sense strand therefore the base that is shown in the variable position is 
the one that was incorporated against the base that was dictated by the modified base in 
the antisense strand. For example if  sequencing shows a G in the variable position the 
base that was inserted opposite the modified base was a C.
5.4 Results and Discussion
Initially the PCR reactions yielded no result The salt content and concentrations 
were varied and fi-esh enzyme was used. Eventually the problem was traced to the 
template. It had to be cut with a restriction enzyme prior to PCR. Once this was 
accomplished using the PVU2 restriction enzyme the PCR reaction worked well. All of 
the modified nucleosides (including 5-nitroindole) and the control strand were subjected 
to PCR in triplicate simultaneously. They were all then purified by agarose gel as can be 
seen in Figure 5.4. All of the reactions produced a product in the desired range except for 
two of the 5-nitroindole strands. These are evident by the bright spot in each of the lanes 
at the point that corresponds to ^proximately 800 base pairs in the pGem and 
Lambda/ECORI HindTTT markers that were used for comparison. One of each of the 
control, 5-nitropyrazole and 5-propynepyrazole were then sequenced. The results of the 
sequencing can be seen in Figure 5.5. Reading from bottom to top (the longer strands are 
closer to the top) the sequence can be picked out as 5 *-AAAACGCATAATCCCATGT in 
the region of interest for all three of the strands. This would indicate that the two 
modified strands had incorporated a C. This is the correct pattern for the control however 
abasic modified nucleosides tend to incorporate a n  Therefore we were skeptical
of the results. This skepticism was augmented by the presence of “shadow”
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Figure S£ Sequencing results of the target oligonucleotide.
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bands underneath each of the true bands. Shadow bands are caused by impure primers in 
the initial or sequencing reactions. They are equivalent to a strand that terminates in the 
same base but is one base shorter in length. The shadow bands were eliminated by 
further purification of the primer that was used in the sequencing reaction. The 
incorporation of the C the modified base still occurred. This was most likely due to 
impure primers used in the original PCR reactions. If the primers were not long enough 
to contain the modified base then the PCR reaction would amplify the strands in the same 
manner as the control. This was shown to be the case when the reaction was repeated
with purified primers. ̂  ̂  With purified primers the base incorporated versus the modified 
nucleosides was an A. Therefore the modified nucleosides were shown to function in 
PCR and incorporate an A as is expected for abasic sites.
5^ Experimental
All oligonucleotides were provided by Midland Certified Reagent Company. The 
enzyme and accompanying buffers were finm Perkin-Elmer (trade name Amplitaq). The 
dNTPs were ^̂ P labeled and acquired fix>m Amersham.
5^.1 Digestion of the Expression Vector ̂ hisF-tac
The expression vector phisF-tac was digested with the PVU2 restriction enzyme 
from New England Biolabs. The total reaction volume was 50 pL for Ipg of plasmid and 
1 pL of enzyme. It was digested at room temperature for 30 minutes and used unpurified. 
5^^ Polymerase Chain Reaction
The basic procedure for the Polymerase chain reaction was provided by Dr. Geoff
Hoops. The following conditions were used to amplify the template DNA containing 
the hisF%ea&'. lOOpL reactions buffered to 100 mM Tris (pH 7.8), 50 mMKCl, 10 pg/mL
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gelatin, 1.5 mM MgC12, ~ 100 pmol sense-strand primer, ~ 100 pmol antisense-strand 
primer, finol quantities of template DNA and 2.5 units of Amplitaq. The reactions were 
run in 500 pL microcentrifuge tubes topped with 75 pL of mineral oil. The samples were 
equilibrated at 95®C for 5min and then were subjected to 31 PCR thermal cycles. The 
cycles consisted of a denature step at 95°C for 1 minute followed by an annealing step at 
37®C for 1 minute and then an extension step at 70®C for 5 minutes. At the end there is a 
10 minute extension at 70°C.
5.5.3 Purification of PCR Product
The product of the PCR reaction was purified by electrophoresis using an agarose 
gel. The gel was 1.2% agarose in a standard TAE buffer (Tris/acetate/EDTA). The gel is 
heated until it boiled and then poured into the horizontal plate and the combs added.
After solidification the samples are loaded using a load buffer composed of Ficoll 400, 
NazEDTA, sodium dodecylsulfate, bromophenyl blue and xylene cyanol. The samples 
are then run in a TAE buffer at 75-100 volts. The commercially available markers 
Lambda/ECORI-Hindin and pGem (purchased from Promega) were run with the samples 
and were used to determine the position of the target oligonucleotide. When the run was 
complete the gel was stained using an ethidium bromide solution and the product band 
was carefully excised. The product was extracted from the agarose gel using the 
Geneclean kit fi-om Bio 101 according to manufacturer’s directions.
5.5.4 Sequencing of PCR product
The PCR product was sequenced using the Thermosequenase Kit from 
Amersham. This kit employs the T7 Sequenase enzyme and all four [a-33P] labeled 
dideoxnucleotide (ddNTP) terminator nucleotides. This ensures that only the properly
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terminated nucleotides are labeled which eliminates background bands. Four reactions 
are set up simultaneously where each corresponds to one of either A, C, G or T 
dideoxynucleosides. The kit was used according to manufacturer’s direction. The 
antisense strand was used as the template. Therefore a primer corresponding to the sense 
strand was used in the reaction. The reaction was cycled 30-35 times and used an 
annealing temperature of 57^C which differs from manufacturer’s directions. Each of the 
four reaction products was “run” in a separate lane using electrophoresis on a 
polyacrylamide gel. The gel was a 10% acrylamide gel that was 19:1 acrylamide to 
bisacrylamide. The gel contains urea and is in a standard TBE buffer (Tris/boric 
acid/EDTA). The samples were run at -  85 watts. The gels were imaged and the bands 
quantified using phosphorimaging on the Storm® system. The percent incorporation of 
each natural nucleoside could be determined by extending a horizontal line across the row 
corresponding to the modified nucleoside (background strands were subtracted) using 
molecular analyst software. The area of the peak corresponding to each of the four lane 
was calculate to determine the percentage incorporation of each nucleoside.
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Chapter 6 
Conclusions
The purpose of this project was to design, synthesize and incorporate several 
modified nucleosides into oligonucleotides. The nucleosides were 5-(2'-deoxy-|3-D- 
ribofuranosyl)-2-hydroxypyrimidine (Figure 6.1, A) and a series of 4-substitiuted 
pyrazole nucleosides including l-(2'-deoxy-P-D-ribofuranosyl)-4-iodopyrazole (Figure 
6.1, B), l-(2'-deoxy-P-D-ribofiiranosyl)-4-nitropyrazole (Figure 6.1, C), l-(2'-deoxy-P- 
D-ribofiiranosyl)-4-propynylpyrazole (Figure 6.1, D), and l-(2'-deoxy-P-D- 
ribofuranosyl)-4-(2-thiazolyl)pyrazole (Figure 6.1, E). The purpose of the research was 
twofold. By generating these nucleosides we hoped to find information about the role 
of base stacking in the stability of the DNA duplex and determine if the appropriate 
choice of nucleosides could be used as “conversion agents” or in ambiguous positions in 
probes and primers. Therefore the nucleosides were synthesized and tested for stability 
in a duplex by thermal melting and in PCR reactions. In addition 1 -(2'-deoxy-P-D- 
ribofuranosyl)-2-hydroxypyriinidine is a C-nucleoside which is of interest in its own 
right because of the potential for anti-viral and anti-cancer properties. The pyrazole 
series of nucleosides were designed to illuminate the differences charge distribution, 
polarizability, and size in the absence of hydrogen bonding have on base stacking in the 
double helix.
Synthesis of the C-nucleoside 5-(2’-deoxy-P-D-ribofuranosyl)-2- 
hydroxypyrimidine was hampered by a number of synthetic hurdles such as starting
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Figure 6.1 Target nucleosides
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materials that were difBcult to prepare and were often stable for only short periods of 
time. In addition both the Pd coupling procedure and the Grignard procedure yielded 
reaction mixtures that were a complex mixture of numerous products. Traces of the 
desired product was occasionally seen but was never isolated. Therefore 5-{2'-deoxy-P- 
D-ribofûranosyl)-2-hydroxypyrimidine is unlikely to be generated by a coupling 
procedure that unites a pre-formed sugar system to a base however it is being 
investigated by the method of construction of the base on the sugar.
One of the starting materials needed for the synthesis of 5-(2'-deoxy-P-D- 
ribofuranosyl)-2-hydroxypyrimidine was a protected furanoid glycal. Therefore an 
investigation of the synthesis of furanoid glycals was conducted. Using a method 
introduced by Pedersen’s, we were able to prepared furanoid glycals having both O-silyl 
and, for the first time, 5-O-acyl protection. The advantages of this method were found 
to be the ability to use a greater generality of protecting groups and increased speed and 
experimental ease with which glycals could be made. Glycals made herein under 
Pedersen conditions, including four previously unknown glycals, had yields that were 
comparable to yields achieved by previous methods, but had fewer steps.
The synthesis of the pyrazole series of nucleosides (Figure 6.1, b-e) were 
successfully synthesized and incorporated into oligonucleotides. The thermodynamic 
properties were then determined by thermal melting. The thermodynamic results 
indicate that the series of pyrazole nucleosides shows a relative increase in 
thermodynamic stability (based on increasing Tm) as the substituents vary fix>m iodo to 
nitro and propyne to thiazole which followed the order predicted by electronic and steric 
considerations. For iodo and propyne the preference was for A over G when pairing
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with the natural nucleosides but thiazole pyrazole showed a preference for G over A and 
nitropyrazole showed a preference for A then T. It is unlikely that the results are based 
on sequence alone because the control sequence with A in the ninth position (the 
position across fiom the modified nucleoside) was the least stable. While non-hydrogen 
bonding nucleosides cannot overcome the energy lost when hydrogen bonds to solvent 
are broken, the choice of a base with an appropriate electronic charge distribution can 
greatly increase the stability over an abasic site or a non-polarizable substituent such as 
the phenyl ring.
In order to determine whether modified nucleoside can fimction as “conversion 
agents” they must be shown to function in PCR reactions. The pyrazole series of 
nucleosides (Figure 6.1, b-e) were incorporated into primers and utilized in PCR 
reactions. All of the reactions were able to produced a product which showed the were 
capable of performing in a PCR reaction primer. Initially the natural nucleoside 
incorporated versus all of the 4-substituted pyrazole nucleosides was a C. This is the 
correct pattern for incorporation versus the control however abasic modified nucleosides 
tend to incorporate an A which caused some skepticism of the results. This was 
discovered to be due to impure primers used in the original PCR reactions. When the 
primers were further purified the sole nucleoside incorporated versus the modified 
nucleosides was an A which is more consistent with literature findings.
Overall the 4-substituted pyrazole nucleosides were successfully synthesized and 
incorporated into oligonucleotides. They were able to function effectively in both 
thermodynamic studies and PCR reactions. The results of both studies proved 
consistent with expectations based on literature precedence.
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Appendix A
Table o f Abbreviations
a ratio of strands in the duplex state to total number of strands
ATP adenosine triphosphate
CIMS chemical ionization mass spectrometry
COSY correlated spectroscopy 2D NMR
CFG controlled pore glass
DEPT distortionless enhancement by polarization transfer ID NMR
dA deoxyadenosine
dC deoxycytidine








DNA deoxyribose nucleic acid
dNTP any of the four natural deoxy nucleosides (dA, dC, dG or dT)
dT deoxythymidine
DPPP bis(diphenylphosphino)propane
FABMS fast atom bombardment mass spectroscopy
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heteroscalar correlation 2D NMR 
1,1,1333-hexamethyldisilazane 
polymerase chain reaction 





melting temperature-temperature (at a specific concentration 
and buffer condition) where half the DNA is in the duplex and 
half is in the single stranded state, 
trimethylsilyl
p-toluoyl(-chloride)
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